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PATIENT PERCEPTIONS OF SHARED DECISION MAKING: WHAT DOES IT MEAN 
AND HOW DOES IT AFFECT PATIENT OUTCOMES? 
 
By Laura Aubree Shay, Ph.D., M.S.S.W. 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor of 
Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2013. 
 
Major Director: Jennifer Elston Lafata, Ph.D. 
Professor, Department of Social and Behavioral Health 
 
 
 
Introduction:  Shared decision making (SDM) has been advocated as an optimal approach to 
medical decision-making.  Yet, little is known about how patients perceive SDM and whether 
patient-defined SDM is associated with patient outcomes. 
Methods: This three-manuscript dissertation used a mixed-methods approach including a 
systematic literature review and both qualitative and quantitative research methods.  The aims 
were to: (1) systematically review the patient outcomes studied in relation to SDM and identify 
under what measurement contexts SDM is associated with which types of patient outcomes; (2) 
use in-depth, qualitative interviews to develop a conceptual model of patient-defined SDM and 
compare this to recent decisions that patients labeled as shared; and (3) apply the model of 
patient-defined SDM to the context of colorectal cancer screening.  
! ! !
!
!
Results:  Study 1 found that 39 studies measured SDM and evaluated it with a patient outcome, 
and only 43% of patient outcomes assessed were significantly associated with SDM.  Patient 
reports of SDM were most likely to be associated with outcomes.   
Study 2 found that patients’ conceptual definition of SDM included four components: exchange 
of information, active listening, patient-self advocacy, and a personalized physician 
recommendation. Patient descriptions of recent decisions labeled as shared ranged from very 
simple recommendations through complex interactions, with the only commonality among 
shared decisions being that the patient and physician ultimately agreed.   
Study 3 found that the most commonly observed component of patient-defined SDM was patient 
self-advocacy (76%) and least common was a personalized physician recommendation (23%).  
Only 9% visits contained all four patient-defined SDM components.  In adjusted models, 
physician provision of information around the process and potential side effects of colorectal 
cancer screening was associated with an increase in screening. There were differences in 
screening rates by the patient’s initial verbal response to the physician recommendation with 
those who initially refused being least likely to be screened (40%) and patients who did not 
verbalize a response to the recommendation being most likely to be screened (70%). 
Discussion:  Findings across the three studies highlight the complexity of studying and 
measuring SDM and emphasize the importance of the patient’s perspective on SDM.   
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Chapter 1: Introduction 
 
In recent years, shared decision making (SDM) has been suggested as an optimal 
approach to medical decision making. 1 While relatively new, the literature on SDM is large and 
growing, with an increasing emphasis on determining the patient outcomes associated with the 
use of SDM. Accordingly, physicians are being encouraged to employ a SDM process with 
patients.  For example, the National Cancer Institute’s monograph on patient-centered 
communication identified decision-making as one of the six core functions of patient centered-
communication, stating that decision-making should be characterized by active engagement by 
both patient and physician. 2 Furthermore, the U.S. Preventive Services Task Force advocates for 
physicians to use SDM when making cancer screening and other preventative health 
recommendations to patients. 3 Despite the widespread endorsement of SDM, there not a clear 
consensus on what SDM actually entails.  Furthermore, there is little knowledge of the empirical 
evidence of either what it means to the parties involved or its impact on outcomes.    
A recent review of SDM literature found that over 61% (257 of 418) of articles provided 
no definition of SDM. 4 However, of the articles that provided definitions, that developed by 
Charles et al. (1997) was most often cited.  Charles et al. (1997) define SDM as having four key 
components that all must be present for a decision to be considered shared: (1) at least two 
participants (patient and physician) are involved in all phases of the decision-making process; (2) 
both parties share information; (3) both parties take steps to build a consensus around the 
decision; and (4) agreement is reached. 5 While this definition was cited three times as often as 
!! %!
any other published definition, 4 there remains some disagreement about the critical components 
of SDM.  For example, the U.S. Preventive Services Task Force’s definition of SDM does not 
require that the patient be involved actively but rather that “the patient has engaged in decision-
making at a level at which he or she desires and feels comfortable.” 3 Others have suggested that 
patient and physician need not reach an agreement to have participated in a SDM process. 4 
However, because the Charles et al. (2007) definition is the most commonly used definition, it 
will be used in this study as the normative definition of SDM, upon which other perceptions of 
SDM will be compared.   
Measurement of SDM 
In addition to differing definitions of SDM in the literature, there are also many 
approaches to measuring SDM in practice.  The two most common methods of measuring SDM 
are observer ratings (via coding of direct observation or recordings of medical consultations) and 
patient self-reports of having participated in SDM.  In recent years there have been a variety of 
formal coding systems created to measure medical decision-making including the Decision 
Analysis System for Oncology scale (DAS-O 6), the Decision Support Analysis Tool (DSAT 7), 
the Shared Decision Making Scale, 8 and the OPTION scale. 9 While some of these coding 
systems have been found to be moderately correlated with one another, they each focus on 
different aspects of SDM and have been validated in separate populations. 10 These differences 
represent the continued disagreement within the academic community about what constitutes a 
shared decision.  Additionally, these coding systems all focus primarily on physician behaviors 
and do not specifically take into account patient involvement. 11  
 The most common way of measuring SDM is through patient self-report. 11 Instruments 
that measure patient self-reports of SDM range from single-item scales (e.g. Control Preference 
!! &!
Scale 12) to multi-item, single dimensional scales (e.g. 9-item Shared Decision making 
Questionnaire SDM-Q-9 13; Facilitation of Patient Involvement Scale 14), through multi-
dimensional scales in which SDM is one of many aspects (e.g. Decisional Conflict Scale 15; 
Decision Evaluation Scales 16; Perceived Involvement in Care Scale 17; Combined Outcome 
Measure for Risk Communication and Treatment Decision-making Effectiveness     
(COMRADE) 18).  As with observer rating instruments, there is no clear gold standard on how to 
measure patient-reports of SDM.   
Patient and physician perceptions of SDM 
While there are many measurement tools for patient reports of SDM, very few studies 
have looked specifically at understanding patient and physician perceptions of SDM.  There is 
evidence, however, that patients may understand SDM differently than researchers.  For 
example, a recent study using audio-recordings of routine annual physical examinations found 
that researcher-defined SDM (using the Charles et al. (1997) definition 5) was not correlated with 
patient reports of SDM. 19 After the exam, patients were asked about their role in the colorectal 
cancer screening decision-making and 47% (171 of 363) reported using a SDM process.  
However, when the audio-recordings of the visits were coded using Charles et al.’s (1997) model 
of SDM, only 0.3% (1 of 363) met the criteria for SDM.  Another recent study measured SDM 
from three perspectives (patient, physician, and observer) and found that observer ratings of 
SDM were completely unrelated to patient or physician ratings, and that patient and physician 
perceptions were only moderately correlated. 20 Taken together, these results point to a likely and 
substantial discrepancy between patients’ and researchers’ perceptions of SDM.  
We know of only two studies that have directly explored the meaning of SDM to 
patients; both qualitative studies conducted in the context of diabetes treatment. 21,22 The study 
!! '!
by Peek and colleagues (2008) looked specifically at the meaning of SDM to African Americans 
with diabetes.  They found that patients emphasized the importance of being able to “tell their 
story and be heard” and reported that information sharing was a vital part of SDM.  However, the 
patients also suggested that negotiation and sharing of the actual decision were not necessary to 
have participated in SDM. 21 The second study by Entwistle and colleagues (2007) used in-depth 
interviews to investigate the meaning of involvement in treatment decisions among 18 adults 
with diabetes. This study also found that patients felt they were involved in decision-making 
when they were able to communicate their views and believe that their physician listened. 22 In 
addition, patients reported that the “feel” of the appointment was important and patients were 
more likely to report being involved when they perceived that their physician respected them.  
The results from these two studies indicate that relational components of SDM may be more 
important to patients than current published definitions of SDM indicate, consistent with the 
recent finding that patient ratings of physician relational communication are associated with 
patient reports of SDM. 19 
Patients may also perceive SDM differently than physicians.  In a study of women in 
treatment for breast cancer, for example, patients and physicians were asked to indicate who 
made the treatment decision using a modification of the Degner et al. (1997) Control Preferences 
Scale. 12,23 This scale is commonly used in measuring patient perceptions of SDM and asks 
patients to rate their role in making a specific decision among 5 choices: (1) I made the final 
decision, (2) I made the final decision after seriously considering my doctor’s opinion, (3) My 
doctor and I shared the responsibility for deciding, (4) My doctor made the final decision but 
seriously considered my opinion, and (5) My doctor made the final decision.  Choice 3 is 
considered a shared decision. 12 On this scale, only 38% of patients and physicians agreed on 
!! (!
who made the treatment decision.  Moreover, 50% of physicians reported making a shared 
decision, while only 30% of patients reported the decision as shared. 23 The poor concordance 
between patient and physician reports indicates a discrepancy in how physicians and patients 
perceive medical decision making.   
Taken together, these studies indicate that there are differences in how patients and 
physicians perceive SDM and that the commonly used Charles’ et al. (1997) definition may not 
represent the perceptions of either group.  Additionally, it is not clear which of these perspectives 
are associated with positive patient outcomes.  Therefore, richer understanding of how patients 
and physicians perceive SDM is required to foster the type of active medical decision making 
that meets patients’ expectations and promotes health. 
SDM and colorectal cancer screening 
The U.S. Preventive Services Task Force (USPSTF), as well as numerous other medical 
societies, recommends that adults aged 50 to 75 receive regular colorectal cancer screening.  
Although there is general evidence to support the benefits of timely screening, there is less 
agreement regarding how patients should be screened.  The USPSTF recommends screening via: 
(1) a fecal occult blood test every year, (2) a flexible sigmoidoscopy every 5 years, or (3) a 
colonoscopy every 10 years. 24 The USPSTF also advises that physicians use a shared decision 
making process when recommending colorectal and other preventive services to patients. 3 
Despite these recommendations, some 40% of the US population remains unscreened for 
colorectal cancer 25 and approximately 50,830 men and women in the United States will die of 
colorectal cancer in 2013. 26 The CDC estimates that 60% of colorectal cancer deaths could be 
prevented if everyone were screened as recommended. 27 
!! )!
Known barriers to colorectal cancer screening include a lack of a physician 
recommendation for colorectal cancer screening, cost, lack of health care insurance, and 
embarrassment or fear over the screening test or preparation for the test. 28 A recent study 
surveyed over 3,000 primary care patients and asked them to identify the most significant 
obstacle to receiving CRC screening among a list of known barriers.  The list included both 
generic barriers, or those that apply across screening modalities, and specific barriers for each 
type of screening modality.  Of the generic barriers, “my healthcare provider never suggested I 
get this test” and “I did not know I should have this test” were most often identified as the top 
overall barrier to screening. 28 These findings indicate that not having a discussion about the need 
for colorectal cancer screening is among the most important barriers to screening, as identified 
by primary care patients.  
Similarly, another recent study found that although physicians pointed to patient factors, 
such as fear of pain and embarrassment about testing, to be important barriers to colorectal 
cancer screening, patients eligible for colorectal cancer screening who had never been screened 
cited not having a physician recommendation as their most important barrier to screening. 29 
While we know that screening use increases with a greater number of primary care visits, and 
thus more opportunities for a physician recommendation, 30,31 a simple recommendation or 
discussion does not guarantee colorectal cancer screening use.  Even among those with a 
physician recommendation, some 40% will still go unscreened. 32 
The content of the discussion is important as well, with more comprehensive discussions 
about colorectal cancer screening being associated with increased screening use. 33 In line with 
these findings, patient reports of having participated in SDM are associated with increases in 
colorectal cancer screening rates, 34 and a recent randomized controlled intervention trial of the 
!! *!
behavioral mediators of colorectal cancer screening found that patient-provider communication 
about colorectal cancer screening was the most important behavioral mediator for screening 
usage. 35  
Thus, colorectal cancer screening discussions and decisions have a direct impact on 
patient health outcomes, illustrating the need for a better understanding of patient and physician 
perceptions of SDM around colorectal cancer screening. 
The aims of my research 
Patient perceptions of having participated in SDM are associated with a variety of 
positive outcomes (e.g. 36,37).  However, little is known about what leads patients to perceive and 
thus report a decision as shared.  As communication and decision-making processes are 
amenable to change, there is potential to foster SDM in practice.  Yet, without an understanding 
of how patients perceive SDM, our ability to foster decision-making processes that are associated 
with positive outcomes is hindered. My research is designed to: (1) understand under what 
measurement conditions SDM is associated with what types of patient outcomes; (2) provide 
insight into how patients perceive SDM; and (3) apply a patient-informed definition of SDM to 
the context of colorectal cancer screening and evaluate the relationship between patient-defined 
SDM and adherence to physician recommended colorectal cancer screening.  With this 
knowledge, future research can focus on developing interventions that help patients and their 
physicians achieve SDM and its associated benefits in practice.  
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Chapter 2:  Where is the evidence? A systematic review of shared decision-making and 
patient outcomes 
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Abstract!
 
 
 
Background: Despite widespread advocacy for shared decision making (SDM), the empirical 
evidence regarding its effectiveness to improve patient outcomes has not been systematically 
summarized.!
!
Purpose: To systematically review the patient outcomes studied in relation to SDM and identify 
under what measurement contexts SDM is associated with which types of patient outcomes. 
 
Data Sources: PubMed (through December 2012) and hand search of article bibliographies. 
!
Study Selection: Studies were included if they empirically (1) measured SDM in the context of 
a patient-clinician interaction, and (2) evaluated the relationship between SDM and at least one 
patient outcome.  
 
Data Extraction: Outcomes were categorized by SDM measurement perspective (patient-
reported, clinician-reported, or observer-rated) and outcome type (cognitive, behavioral, or 
health). 
!
Data Synthesis: Thirty-nine studies met inclusion criteria.  Thirty-three used patient-reported 
SDM, six used observer-rated, and two used clinician-reported SDM.  Ninety-seven unique 
patient outcomes were assessed; 51% cognitive, 28% behavioral, and 21% health.  Only 43% of 
assessments (n=42) found a significant and positive relationship between SDM and the patient 
outcome. Results varied by SDM measurement perspective and outcome category.  52% of 
outcomes assessed with patient-reported SDM were significant and positive, compared to 21% 
with observer-rated and 0% with clinician-reported SDM.  Regardless of measurement 
perspective, cognitive patient outcomes were most likely to be associated with SDM (54%), 
compared to 37% of behavioral, and 25% of health outcomes.   
!
Conclusions: SDM, when perceived by patients as occurring, seems to improve cognitive 
outcomes, such as decisional conflict. Yet, available empirical evidence does not yet support an 
unequivocal relationship between SDM and patient behavioral and health outcomes.   
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Introduction 
 Since the early 1980s, shared decision making (SDM) has been suggested as an optimal 
approach to making health care decisions. 1,38,39 Both the Institute of Medicine and the U.S. 
Preventive Services Task Force have advocated for clinicians to use SDM when making 
preventive health and treatment recommendations. 3,40 Most recently, language contained in the 
Affordable Care Act specifically calls for programs to facilitate shared decision making and the 
establishment of the Patient Centered Outcomes Research Institute. 41 Furthermore, a recent 
systematic review of patient decision-making preferences found that the majority of patients 
prefer to be actively involved in decision-making and that the trend for a preference for shared 
decisions has increased over time. 42 
While the concept of SDM is often intertwined with decision aids, there are conceptual 
differences in the two.  Although there is not universal agreement around a definition of SDM, it 
is generally thought to be a process in which a patient and clinician collaborate to make the best 
possible medical decision for the patient. 43 Decision aids most often are defined as tools to help 
patients to become better informed about the potential benefits and harms of treatment choices, 
to weigh the pros and cons based on their unique values and medical characteristics, and to be 
prepared to actively participate with their clinician in making a medical decision. 44 Thus, while 
both SDM and decision aids have the same end goal of a patient making a well-informed and 
value-concordant decision, 44-46 decision aids may or may not employ SDM to reach this end and 
SDM can occur outside of the use of a decision aid.   
Previous systematic reviews have pointed to the effectiveness of decision aids for 
improving patient outcomes, 44 but as evidenced by these reviews, use of a decision aid does not 
ensure that SDM occurred.  For example, in the most recent Cochrane review of decision aids 
!! $$!
(2011), only 16 of the 86 randomized trials reviewed explicitly measured the effects of decision 
aids on patient participation in decision-making.  Among these studies, there were no differences 
in patient reports of having participated in SDM between those given a decision aid or those 
receiving usual care. 44 Thus, the positive effects of decision aids on patient outcomes may not be 
attributable to SDM.  Moreover, the empirical evidence surrounding SDM is not confined to 
studies of decision aids only. 
Despite widespread advocacy for SDM and a growing body of literature evaluating its 
use, the empirical evidence regarding its effectiveness as a mechanism to improve patient 
outcomes has not been systematically summarized.  Additionally, SDM has been measured in a 
variety of ways across studies, and whether these different measurement perspectives are 
differentially associated with patient outcomes is not known.   The objectives of this systematic 
review are to (1) describe the patient outcomes that have been studied in relation to SDM and (2) 
identify under what measurement contexts SDM is associated with which types of patient 
outcomes. 
Methods 
Conceptual Framework 
The conceptual framework guiding this systematic review was adapted from models by 
Street and colleagues 47 and Kreps and colleagues 48 (Figure 2.1).   In their model of pathways in 
which clinician-patient communication can lead to better health, Street and colleagues posit that 
while communication between clinicians and patients, including SDM, can lead to improved 
health outcomes directly, in most cases communication affects health indirectly through 
proximal and intermediate outcomes.  As proposed by Kreps and colleagues in their 
Transformation Model of Communication and Health Outcomes, 48 we change the categorization 
!! $%!
of outcomes from a temporal classification to a conceptual classification. This latter model 
asserts that patient outcomes should be categorized by their impact on the individual across three 
categories:  cognitive, behavioral, and physiological.  Cognitive outcomes include knowledge, 
attitudinal, and affective/emotional effects. Behavioral outcomes include both adherence to 
recommended treatments and adoption of health behaviors.  Physiological outcomes (which we 
have broadened to label as health outcomes) include quality of life, self-rated health, and 
biological measures of health (e.g. blood pressure). 48 
!
!
Adapted from Street et al. (2009) and Kreps et al. (1994) 
! !
 
Figure 2.1:  Conceptual framework linking SDM to patient outcomes. 
!
 
Inclusion and Exclusion Criteria 
Studies were included in this review if they empirically (1) measured SDM in the context 
of a patient-clinician interaction, and (2) evaluated the relationship between SDM and at least 
one patient outcome.  Excluded studies were those not in the context of a patient-clinician 
interaction, that reported only qualitative data, or that were reviews or commentaries.  Also 
excluded were studies that evaluated the relationship between SDM and patient outcomes but did 
!! $&!
not directly measure SDM. As such, evaluations of decision aids and other interventions which 
assumed that use of the decision aid led to a SDM process, but which did not explicitly measure 
SDM were excluded.  
Search Strategy 
We began with the primary search strategy outlined by Makoul and Clayman (2006) in 
their systematic review of the SDM literature. 4 Specifically, in January 2013, we conducted a 
PubMed search for English-language articles published through December 31, 2012 with the 
words shared decision making in the title or abstract.  Makoul and Clayman reasoned that this 
search strategy captured articles with a clear focus on shared decision making in the medical 
literature and that the simple approach allows for reproducibility for future studies. 4 No start 
date was specified so that all studies published up through the end of 2012 would be included.  
The resulting abstracts were reviewed for inclusion and exclusion criteria. I read and reviewed 
the full text of those articles meeting the study inclusion criteria and collected any non-redundant 
references to SDM.  
Among study eligible articles, patient outcomes were defined as observed or self-reported 
effects in association with a specific patient-clinician encounter or overall medical care.  Because 
a number of eligible studies evaluated more than one patient outcome in relation to SDM, the 
unit of analysis for this review is a patient outcome.  
Classification framework  
There are multiple ways that SDM can be measured. 4,11 A priori we expected the 
measurement of SDM to fall into two primary categories: patient self-reports of SDM or 
observer-ratings of the use of SDM (usually via structured coding of audio-recordings).  Our 
review of the literature also revealed a third category: clinician reports of using SDM with 
!! $'!
patients.  In addition to considering the SDM measurement perspective, as indicated in the 
conceptual framework (Figure 2.1) we also considered the type of outcome evaluated using the 
three classifications proposed in the Transformation Model of Communication and Health 
Outcomes 48: cognitive, behavioral, or health outcome.  Combined, these categorizations resulted 
in a 3 x 3 classification framework that was used to structure the results of the systematic review 
(Figure 2.2). 
 
SDM 
Measurement 
Perspective 
 
Patient Outcome Category 
 
  
Cognitive Behavioral Health 
Patient self-
reported 
  
   
Clinician self-
reported 
  
   
Observer 
rated 
  
   
!
Figure 2.2: Categorization framework of patient outcome categories by SDM measurement 
type 
 
 
Assessment of the quality of studies 
We used a modified version of the Systematic Appraisal of Quality in Observational 
Research (SAQOR) tool to assess the quality of included studies. 49 SAQOR was created for use 
in systematic reviews to assess the quality of observational studies.  Each study was rated as 
adequate, inadequate, or unclear across six categories: sample, research design, quality of 
measures, follow-up, distorting influences (confounders), and reporting of data. A total score for 
each study is computed by counting the number of categories marked adequate.   Thus the total 
quality score has a range of 0 to 6, with higher scores indicating higher quality studies. Total 
!! $(!
scores of 5 or 6 represent high quality, scores of 3 or 4 represent moderate quality, and 0 to 2 
represent low quality observational studies. 50 
Results 
Overview of studies 
Forty-one publications, 10,17,51-89 representing 39 unique studies, met the inclusion criteria 
(Figure 2.3; Table 2.1 on page 26).  Thirty-four of the 41 articles meeting inclusion criteria were 
published in the last ten years and the earliest study meeting the inclusion criteria was published 
in 1989.51  
The 39 studies were conducted across a variety of clinical contexts. Fourteen studies 
(36%) were conducted in the context of cancer care, and almost three-quarters of these (n=10) 
focused specifically on breast cancer treatment and surgery decisions. Other clinical contexts 
studied included mental health (n=5), diabetes (n=5), serious injury (n=3), heart disease (n=2), 
HIV (n=2), and general primary care (n=2) among others (n=6). 
 
Figure 2.3: Search strategy and selection results 
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Quality assessment 
The SAQOR quality scores ranged from 2 to 6, with a median score of 3 (Table 2.1).  
Across the 39 studies, six (15%) received a high quality rating, 25 (64%) moderate, and eight 
(21%) low.  Most of the studies were either cross-sectional or prospective surveys in which data 
were collected either before and after, or only after, a consultation with a clinician.  Nine of the 
39 studies were conducted in the context of a clinical trial. 53,58,64,65,68,70,72,77,82 Eight of these were 
a secondary analysis of a previous RCT. 53,58,64,72,77,82 In these studies, the analysis either was 
conducted without regard to group assignment, 77,82 group assignment was used as a predictor 
variable in the model, 58,64,68,72 or the results were tested separately to see if group assignment 
confounded the relationship between measured SDM and patient outcomes. 53,65 The ninth study 
included a patient self-report of participation in SDM, but only tested the association of patient-
reported SDM with a patient outcome among those in the experimental group. 70 Thus, none of 
the included RCTs evaluated the association between SDM and a patient outcome with a 
randomized design.  
SDM Measurement Perspective  
Eighty-five percent of studies measured SDM from the patient’s perspective (n=33), 15% 
(n=6) via observer rating, and two (8%) used clinician-reports to measure SDM. In two 
studies,74,81 the same patient outcome was assessed for its association with SDM from different 
SDM measurement perspectives and these analyses are considered separately. 
Patient-reported SDM was measured in a variety of ways across studies. The most 
commonly used measure was a modified version of the Control Preference Scale 12 in which 
patients rate their perceptions about their level of involvement in decision-making (n=13 
studies). The second mostly commonly used patient-reported measure of SDM was the multi-
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item Patient Involvement in Care Scale, 17 which was used in four studies.  A variety of other 
single and multi-item measures of SDM were used (n=16 studies). 
Five of the six studies that included observer ratings of SDM used the OPTION scale in 
which observers rate the communication between patient and clinician on 12 items. 90 The 
OPTION scale is either completed by an in-person observer in real time or is used to rate audio-
recordings of patient/clinician interactions.   
Clinician-reported SDM was used in two studies, both in the context of diabetes. 81,84 One 
of these used a modified version of the Control Preference Scale 12 and the other used a 9-item 
Self-Assessment Questionnaire. 91 
Patient Outcomes Evaluated 
The number of patient outcomes evaluated per study ranged from 1 to 7 with a total of 95 
unique patient outcomes and 97 unique patient outcome-SDM measurement pairs assessed 
across the 39 studies (Table 2.2).  Among the 97 outcome assessments, 51% (n=50) were 
cognitive, 28% (n=27) behavioral, and 21% (n=20) health outcomes. Half of the cognitive 
variables studied were around patient satisfaction (n=25).  Beyond satisfaction, cognitive 
variables included concerns/anxieties about the illness (n=5), decisional conflict (n=4), anxiety 
following the consultation (n=4), confidence in the decision (n=2), and knowledge (n=2) among 
others. The most frequent behavioral variable assessed was around the treatment decision itself 
(n=10), with nine of these regarding breast cancer treatment decisions. Other behavioral 
variables include treatment/medication adherence (n=7), health behaviors (n=3), and others.  
Health outcomes included patient ratings of overall health (n=6) and quality life (n=3), 
depressive symptoms (n=5) and other patient-reported measures (n=2), as well as a blood 
pressure (n=2) and other physiological measures (n=2).   
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Table 2.2:  Patient outcomes assessed by SDM measurement perspective and outcome 
category (n=97)  
SDM 
Measurement 
Category 
 
 Patient Outcome Category  
 
 
Cognitive 
(n=50) 
Behavioral 
(n=27) 
Health 
(n=20) 
Patient-
reported Satisfaction with care (x7) Decision about breast cancer treatment (x7) Pt rated health/symptoms (x6) 
SDM Concern/anxiety about illness (x5) Medication/treatment adherence (x6) Depressive symptoms (x5) 
 Satisfaction with decision (x5) Diet Quality of life (x3) 
 Decisional Conflict (x3) Disclosure of CAM use Anxiety 
 Satisfaction with consultation (x3)  Exercise Blood pressure 
 Anxiety after consultation (x2) Number of treatment strategies agreed upon Emotional functioning 
 Control over medical problem (x2) Receipt of depression care   
 Health care empowerment (x2) Stress management behaviors   
 Knowledge (x2) Use of CAM   
 Satisfaction with information received (x2)     
 Trust in physician (x2)     
 Confidence in decision     
 Predicted discomfort     
 Predicted functional capacity     
Clinician-
reported Satisfaction with provider communication Medication adherence Blood pressure  
SDM   Receipt of dilated eye exam Hemoglobin A1c  
   Receipt of hemoglobin A1c assessment Lipid level 
   Receipt of lipid assessment   
Observer-
rated Satisfaction with decision (x 4) Decision about breast cancer treatment (x 2)   
SDM Anxiety immediately after consultation (x 2) Decision about treatment for arrhythmia   
 Satisfaction with consultation (x 2)     
 Confidence in decision     
 Decisional conflict     
 Satisfaction with physician's SDM skills     
 
Associations between SDM and patient outcomes 
As can be seen in Table 2.3, less than half (n=42; 43%) of assessments found a 
statistically significant and positive relationship between SDM and the patient outcome.  Results 
varied by both the SDM measurement perspective and the category of patient outcome. When 
SDM was measured from the perspective of the patient, regardless of the outcome category, 
assessments were more likely to result in significant associations.  Across all outcomes assessed, 
52% were significantly and positively associated with patient-reported SDM, compared to only 
21% of outcomes when SDM was observer-rated and 0% when SDM was clinician-reported.  
Similarly, regardless of how SDM was measured, cognitive patient outcomes were most likely to 
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be associated with SDM.  Fifty-four percent of cognitive outcomes were positively associated 
with SDM, compared to 37% of behavioral, and 25% of health patient outcomes.   
Three studies found negative effects of SDM on patient outcomes including an increase 
in decisional conflict, 58 a decrease in patient satisfaction, 63 and an increase in patient reports of 
the impact of breast cancer on their life. 67 All three were cognitive patient outcomes in the 
context of patient self-reports of SDM. 
 
Table 2.3:  Summary of results by SDM measurement perspective and patient outcome 
category 
SDM 
Measurement 
Perspective  Patient Outcome Category 
 Cognitive   Behavioral   Health   Total   
  n %  n %  n %  n % 
Patient 
reported Positive* 25 66% Positive 9 45% Positive 5 29% Positive 39 52% 
 NS* 10 26% NS 11 55% NS 12 71% NS 33 44% 
 Negative*  3 8% Negative 0 0% Negative 0 0% Negative 3 4% 
 Total measured 38  Total measured 20   Total measured 17   Total measured 75   
                         
Clinician 
reported Positive  0 0% Positive  0 0% Positive  0 0% Positive  0 0% 
 NS 1 100% NS 4 100% NS 3 100% NS 8 100% 
 Negative  0 0% Negative  0 0% Negative  0 0% Negative  0 0% 
 Total measured 1  Total measured 4   Total measured 3   Total measured 8   
                         
Observer rated Positive  2 18% Positive  1 33% Positive  0 -- Positive  3 21% 
 NS 9 82% NS 2 67% NS 0 -- NS 11 79% 
 Negative  0 0% Negative  0 0% Negative  0 -- Negative  0 0% 
 Total measured 11  Total measured 3   Total measured 0   Total measured 14   
                         
Total Positive  27 54% Positive  10 37% Positive  5 25% Positive  42 43% 
 NS 20 40% NS 17 63% NS 15 75% NS 52 54% 
 Negative  3 6% Negative  0 0% Negative  0 0% Negative  3 3% 
 Total measured 50   Total measured 27   Total measured 20   Total measured 97   
 
• Positive refers to a significant, positive (i.e. beneficial) association between SDM and the patient 
outcome.  NS refers to a non-significant association.  Negative refers to a significant, negative 
(i.e. non-beneficial) association between SDM and the patient outcome 
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 five health outcomes that were found to be associated with SDM were patient self-reported 
outcomes, including a one-item ratings of general health rating,72 discomfort,51 symptom 
improvement, 51 general medical improvement, 51 and measure of depressive symptoms rated on 
the Center for Epidemiologic Studies-Depression scale. 65 Among these, only depressive 
symptoms were measured using a multi-item, previously validated scale. 65 None of the four 
physiological measures assessed were associated with SDM. 70,84 
Discussion 
Relatively few empirical evaluations have been conducted between SDM and patient 
outcomes.  We found a total of 39 unique studies, which included 97 assessments of the 
relationship between an empirical measure of SDM in the context of a patient-clinician 
interaction and a subsequent patient outcome.  Cognitive outcomes were assessed most often and 
were primarily patient reports of satisfaction, decisional conflict, or other perceptions 
immediately after an interaction with a clinician. Furthermore, relative to behavioral and health 
outcomes, cognitive outcomes were most often found to be significantly and positively 
associated with SDM.  While cognitive outcomes are important and represent SDM’s origins as 
an ethical call to increase patient autonomy, 39,92 there has been a shift towards understanding 
how patient-clinician communication, including SDM, may be associated with more distal 
behavioral and health outcomes. 2,47,93  
Although there are strong ethical and interpersonal reasons to advocate for SDM, our 
findings illustrate the continued uncertainty surrounding SDM as a mechanism to improve 
patient outcomes.  Regardless of the type of patient outcome considered or the SDM 
measurement employed, empirical evaluations more often than not have found no positive and 
statistically significant relationship between SDM and a patient outcome.  The one exception is 
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among assessments that evaluated a cognitive patient outcome in relation to patient-reported 
SDM.  Within these assessments, the majority (66%) found a significant and positive 
relationship between SDM and a subsequent patient outcome. Notably lacking were any studies 
that evaluated the association between observer-rated SDM and patient health outcomes.  
Clinician reports of SDM were also rare, with the eight such associations evaluated here coming 
from only two independent studies, with none found to have a significant association with a 
patient outcome.  
Results from this review indicate that the link between SDM and health patient outcomes, 
in particular, has yet to be fully established.  Our review highlights several important points 
regarding the assessment of SDM and patient health outcomes.  First, health outcomes were least 
studied.  Second, when health outcomes have been assessed in relation to SDM, the outcomes 
have most often been measured via patient self-report, and often with un-validated instruments.   
In total, only five of the 20 (25%) health outcomes evaluated were found to be associated with 
SDM, and four of these used single-item un-validated measures.  Furthermore, we identified only 
four physiological measures of patient health (blood pressure, hemoglobin A1C, and lipid level) 
that have been evaluated for their association with SDM, and none of these evaluations identified 
a statistically significant relationship. 70,84 Despite the fact that conceptual models of patient-
clinician communication hypothesize that communication is most likely to have an indirect effect 
on patient health outcomes,  the studies included here tested only for a direct effect of SDM on 
health outcomes.  Without mediation or path analysis models designed to specifically examine 
indirect effects, the relationship between SDM and patient health outcomes is likely to remain 
elusive. 
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As previously reported, 4,11 within the patient-perceived SDM measurement category a 
wide range of measures of patient perceptions of SDM are currently being used.  While 
variations of the Control Preference Scale 12 are most commonly used, we found 16 different 
instruments used across the 33 studies that measured SDM via patient self-report.  Whether the 
Control Preference Scale or some other instrument is used to capture patient-reported use of 
SDM, more often than not, items contained in these instruments do not enable an understanding 
of what it is about the decision-making process that leads a patient to report that it was shared.  
This is particularly troubling as several recent studies have found that observer ratings of SDM 
do not predict patient reports of having participated in a shared decision. 19,74,94  These results, 
combined with our findings that when positively associated with a patient outcome it is patient-
perceived SDM, and not observer-rated SDM that is important, only serve to highlight the 
challenge and need to understand what leads a patient to label a decision as “shared.” Without 
such an understanding, our ability to foster SDM processes in practice will continue to be 
hindered as will our ability to fully understand the impact of SDM on patient outcomes. 
Notably lacking among the SDM literature are randomized trials evaluating the impact of 
a communication/decision-making intervention on patient outcomes that empirically measure the 
communication/decision-making process used.  There have been many RCTs in recent years that 
have evaluated the effects of some type of communication or decision-making intervention on 
patient outcomes.  These interventions most often center on a decision aid, but also include 
patient or clinician communication training interventions. 95,96 These studies have rarely included 
an empirical measure of SDM, instead assuming SDM to have occurred based upon group 
assignment.  Our review identified only 9 studies conducted in the context of a randomized 
trial,53,58,64,65,68,70,72,77,82 and despite the design of the parent study, none evaluated the association 
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of SDM and a patient outcome in the context of the randomized design.   To compliment 
thoughtful conceptual models that hypothesize the paths between patient and clinician 
communication behaviors and patient outcomes (e.g.47), well designed studies are needed that 
formally test whether decision-making and communication interventions lead to increase SDM, 
and then whether it is these increases in SDM (or something else) that are associated with health 
outcomes.  SDM may mediate, or even moderate the relationship between communication or 
decision-making interventions and patient outcomes, but as of yet these relationships remain 
untested in the empirical literature.   
Limitations 
Our conceptual framework examines impact of SDM on patient outcomes across two 
important domains – the way in which SDM was measured and the category of patient outcome.  
However, there are undoubtedly other dimensions that are important to understanding the 
relationship between SDM and patient outcomes.  For example, the clinical context in which the 
decision was made and the nature of the decision itself (prevention vs. acute treatment vs. 
chronic treatment decisions, etc.) may influence the impact of SDM on patient outcomes.  Given 
the relatively small number of studies identified as eligible for study inclusion, we were not able 
to further categorize studies for this first systematic review.  
We recognize that SDM (particularly patient perceptions of SDM) may not be limited to 
the context of one visit between a patient and clinician, but rather patient reports of SDM may be 
influenced by the prior relationship between the patient and clinician or by the influence of other 
parties in the decision. 19 This is especially likely to be true in primary care and chronic disease 
contexts in which patients and their clinicians often make multiple decisions over the course of 
many visits.  However, none of the studies identified here measured SDM across a long-standing 
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relationship, and thus we are unable to discuss how SDM may affect patient outcomes over time. 
Additionally, all of the studies reviewed here examined SDM in the context of a patient and 
clinician only, limiting our ability to examine the effects of having family members or others 
participate in decision-making. 
Furthermore, the results and conclusions presented here may be influenced by publication 
biases.  Although we were careful to review articles identified as eligible for inclusion for 
additional non-redundant references, we did not attempt to identify and include results from un-
published studies.  Additionally, due to the diversity of patient outcomes assessed across studies 
we were not able to use meta-analysis methods.  As consensus is built around the measurement 
of SDM and the patient outcomes most salient to SDM, future systematic reviews may be able to 
use a meta-analysis to formally combine and assess the evidence across studies.   
Conclusion 
Our review suggests that when patients report that they have participated in shared 
decision making, they are likely to enjoy better cognitive outcomes, such as improved 
satisfaction and less decisional conflict.  Furthermore, patient reports are the only SDM 
measurement perspective found to be associated with patient health outcomes, albeit in a 
minority of those studies.  The challenge with these findings is that we do not know what leads a 
patient to report a decision as shared, and thus do not know how to foster SDM and its associated 
benefits in practice.  Thus, not only should future studies continue to address the impact of SDM 
across a continuum of patient outcomes and clinical settings, they should also address the 
methodological challenges associated with such evaluations.  Patients increasingly report a desire 
to engage in shared decision making, and SDM remains an important tool to promote patient 
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autonomy and satisfaction.  However, our findings indicate that the link between SDM and 
patient behavioral and health outcomes has yet to be fully established. 
 
 
!! "#!
Table 2.1:  Summary of included studies by SDM measurement perspective 
 
First Author Year 
Diseases 
context n Design 
SDM 
Measurement 
Patient outcomes 
measured Summary of results 
Quality 
rating 
      
(patient; 
provider 
if 
reported)       
SDM associated with: 
(unless noted the association 
was significant in the expected 
direction in a multivariate 
model) 
SAQOR 
score 
and 
rating 
Patient self-
reported SDM           
Brody 1989 
Primary 
care, 
various 117 
Survey at baseline, 1 
day, and 1 week post-
consultation 
1-item variant of 
Control 
Preference 
Scale (CPS) 
Sense of personal 
control; concern 
regarding illness; 
satisfaction with the 
physician; expediting 
discomfort; 
experiencing 
dysfunction; symptom 
improvement; general 
medical improvement. 
SDM associated with greater 
sense of personal control, lower 
post-visit levels of concern 
regarding illness, less discomfort, 
greater symptom improvement 
and greater improvements in 
overall medical condition one 
week after visit. 
 
No association between SDM and 
experiencing dysfunction one 
week after visit. 
4 
 
Moderate 
Lerman 1990 
Primary 
care, 
various 83 
Cross-sectional 
survey after primary 
care visit 
13-item 
Perceived 
Involvement in 
Care Scale 
(PICS) 
Satisfaction with the 
art of care; satisfaction 
with the technical 
aspects of care; 
understanding about 
illness; reassurance 
regarding health 
status; perceived 
control over medical 
problem; predicted 
discomfort; predicted 
functional capacity 
SDM  associated with satisfaction 
with the technical aspects of care, 
understanding about illness, 
reassurance regarding health 
status, perceived control over 
medical problem, and predicted 
functional capacity.   
 
No association between SDM and 
satisfaction with the art of care or 
predicted discomfort. 
3 
 
Moderate 
Chambers 1999 
Asthma 
(primary 
care) 394 
Cross-sectional 
survey, SDM 
questions are not 
about one specific 
interaction 
1-item variant of 
CPS 
Regular use of inhaled 
corticosteroids 
SDM associated with regular use 
of inhaled corticosteroids as 
prescribed. 
3 
 
Moderate 
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Gattellari  2001 
Cancer, 
various 233; 9 
Audio-recorded 
consultation and 
surveys at baseline, 
immediately after 
consultation, 1 week, 
and 2 weeks post-
consultation 
1-item variant of 
CPS 
Anxiety immediately 
after the consultation; 
anxiety 2 weeks after 
the consultation; 
satisfaction with the 
consultation; 
satisfaction with the 
information and 
emotional support 
received; recall of 
information. 
SDM associated with satisfaction 
with the consultation and 
satisfaction with the information 
and emotional support received. 
 
No association between SDM and 
anxiety at either time point or 
recall of information. 
6 
 
High 
Golin 2002 Diabetes 198 
Face-to-face 
interviews before and 
after consultation 
9-item 
Facilitation of 
Patient 
Involvement in 
Care Scale 
(FPI) 
Satisfaction with the 
visit 
SDM associated with satisfaction 
with the visit. 
 
In a subgroup analysis, this 
association was found to be true 
only for women. 
4 
 
Moderate 
Heisler 2002 Diabetes 1431 
Cross-sectional 
mailed survey 
4-item Provider 
Participatory 
Decision-
Making Style 
Scale 
(PDMstyle) 
Patient-reported 
diabetes self-
management 
In separate multivariate analyses, 
both components of SDM are 
positively associated with patient-
reported diabetes self-
management.  When both 
components of SDM are included 
in one model , only information 
giving remains significant. 
3 
 
Moderate 
Keating 2002 
Breast 
cancer 1081 
Cross-sectional 
phone survey 
1-item rating of 
decision making 
role developed 
for this study 
Satisfaction with 
treatment information 
provided; satisfaction 
with treatment choice; 
receipt of breast 
conserving surgery 
(versus mastectomy) 
SDM  associated with satisfaction 
with the amount of treatment 
information provided. 
 
There was no association 
between SDM and satisfaction 
with treatment choice or receipt of 
breast conserving surgery. 
3 
 
Moderate 
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Heisler 2003 Diabetes 127; 50 
Cross-sectional 
survey of patient and 
physician 
1-item variant of 
CPS 
Number of treatment 
strategies agreed upon 
by patient and provider 
No association in multivariate 
analysis. 
 
In a bivariate analysis, SDM is 
positively associated with the 
number of treatment strategies 
agreed upon by the patient and 
provider.  After multivariate 
adjustment,  the association was 
no longer significant. 
4 
 
Moderate 
Legare 2003 Menopause 167 
Cross-sectional 
survey of both the 
patient and physician 
immediately after 
consultation 
1-item variant of 
CPS 
Difference between 
physician and patient 
decisional conflict 
SDM associated with the 
physician experiencing greater 
decisional conflict that then patient 
(unexpected direction). 
3 
 
Moderate 
Ananian 2004 
Breast 
cancer 181 
Cross-sectional 
survey after decision 
before surgery 
1-item variant of 
CPS 
Decision about surgery 
(mastectomy alone or 
mastectomy with 
reconstruction); 
Decision about timing 
of reconstruction 
among those receiving 
mastectomy with 
breast reconstruction  
(immediate or delayed 
reconstruction) 
 
No associations in multivariate 
analysis.  
 
In bivariate analysis, SDM 
associated with choice of having 
breast reconstruction .  
2 
 
Low 
Lantz 
(Also Katz 
2005; Bleicher 
2008)* 2005 
Breast 
cancer 1633 
Cross-sectional 
mailed survey study 
on average 7 months 
after diagnosis 
1-item variant of 
CPS 
Satisfaction with 
surgery received; 
satisfaction with 
decision process; 
decisional conflict; 
decision about surgery 
(mastectomy or breast 
conserving surgery) 
SDM associated with greater 
satisfaction with surgery received, 
greater satisfaction with the 
decision process, and less 
decisional regret.   
 
Patients who reported SDM were 
more likely to receive 
mastectomy.  In a subgroup 
analysis, this association was only 
supported for white women and 
not for racial groups (Katz). 
4 
 
Moderate 
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Nekhlyudov 2005 
Breast 
cancer 431 
Cross-sectional 
mailed survey study 
1-item variant of 
CPS 
Satisfaction with 
decision 6 months 
after surgery; current 
satisfaction with 
decision; current 
breast cancer concern; 
current depressive 
symptoms 
SDM (versus patient-controlled 
decisions) associated with lower 
satisfaction 6 months after surgery 
and lower current concern about 
breast cancer. 
 
No associations between SDM 
and current satisfaction or current 
depressive symptoms. 
4 
 
Moderate 
Thapar 2005 Epilepsy 975; 115 
Cross-sectional 
survey study; 
Secondary analysis of 
RCT 
Not described 
beyond "patient-
rated shared 
decision 
making" 
Satisfaction with 
physician care of 
epilepsy 
SDM associated with satisfaction 
with physician epilepsy care. 
3 
 
Moderate 
Clever† 2006 
Depression 
(primary 
care) 1706 
Survey at baseline, 6, 
18, and 24 months 
post-consultation; 
Secondary analysis of 
4 RCTs combined 
1-item rating of 
involvement in 
decision making 
developed for 
this study 
Receipt of guideline 
concordant depression 
care (antidepressant 
medication or 
counseling); 
depressive symptoms 
SDM associated with receipt of 
guideline concordant depression 
care and resolution of major 
depression symptoms over 18 
months of follow up. 
6 
 
High 
Loh 2006 
Depression 
(primary 
care) 207; 30 
Longitudinal survey 
study - data collected 
at initial consultation 
and 6-8 weeks later 
6-item patient 
participation 
scale first used 
by Mah-Son-
Hing et al. 1999 
Depressive symptoms; 
treatment adherence 
SDM associated with treatment 
adherence.   
 
No direct association between 
SDM and depressive symptoms, 
but there was an indirect effect of 
SDM on depressive symptoms 
through treatment adherence. 
4 
 
Moderate 
Mandelblatt 2006 
Breast 
cancer 718 
Cross-sectional in-
person survey 
4-item subscale 
of PICS 
Decision about surgery 
(mastectomy or breast 
conserving surgery); 
receipt of adjuvant 
therapy;  satisfaction 
with care; impact of 
breast cancer on life 
SDM associated with adjuvant 
treatment use,  satisfaction with 
care, and with impact of breast 
cancer on life (unexpected 
direction).   
 
In a subgroup analysis, SDM only 
associated with adjuvant 
treatment use among women 
aged 67 to 74, and not among 
those aged 75 and older. 
 
No association between SDM and 
decision about type of surgery. 
4 
 
Moderate 
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Swanson† 2007 
Depression 
(primary 
care) 1317 
Survey at baseline, 6, 
18, and 24 months 
post-consultation; 
Secondary analysis of 
4 RCTs combined 
3-item rating of 
involvement in 
SDM developed 
for this study Satisfaction with care 
SDM associated with satisfaction 
with care. 
5 
 
High 
Mahone 2008 
Serious 
mental 
illness 85 
Cross-sectional 
survey; Secondary 
analysis of 4 RCTs 
1-item variant of 
CPS 
Medication adherence 
in the past one month; 
medication adherence 
in the past 6 months; 
quality of life No associations. 
3 
 
Moderate 
Deinzer 2009 
Hypertensi
on (primary 
care) 86; 15 
Prospective 
controlled clinical trial 
Combined 
Outcome 
Measure for 
Risk 
Communication 
and Treatment 
Decision 
Making 
Effectiveness 
scale 
(COMRADE) 
Blood pressure 
(diastolic and systolic) 
No association. 
 
In a subgroup analysis, patients 
with a high interest in participating 
in SDM who reported an increase 
in SDM had a decrease in 
diastolic and systolic blood 
pressure. 
3 
 
Moderate 
Hawley 2009 
Breast 
cancer 1651 
Cross-sectional 
mailed survey 
1-item variant of 
CPS 
Receipt of mastectomy 
as the initial surgery 
treatment 
No association between SDM and 
rates of mastectomy as the initial 
surgery in multivariate model. 
 
In bivariate analysis, women who 
reported SDM were less likely to 
receive mastectomy initially than 
those who reported a patient-
based decision. 
4 
 
Moderate 
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Janssen 2009 
Serious 
injury, 
various 90 
Cross-sectional 
survey 
4-item scale 
measuring SDM 
as part of the 
larger Cologne-
Patient-
Questionnaire 
(CPQ) 
Self-rated health: 
"Would you say your 
health in general is 
excellent, very good, 
good, fair, or poor?" 
SDM associated with better self-
related health. 
4 
 
Moderate 
van den 
Bergh 2009 
Prostate 
cancer 129 
Cross-sectional 
mailed survey study 
1-item rating of 
involvement in 
decision making 
developed for 
this study 
Decisional conflict; 
depressive symptoms; 
generic anxiety; 
prostate cancer 
specific anxiety 
SDM associated with decreased 
decision conflict. 
 
No association between SDM and 
depressive symptoms, generic 
anxiety, or prostate cancer 
specific anxiety. 
5 
 
High 
Burton ‡ 2010 
Heart 
disease 85 
Surveyed before and 
after consultation.  
Med students 
observed interaction 
and coded using 
OPTION scale 13-item PICS 
Confidence in the 
decision 
SDM associated with confidence 
in decision. 
2 
 
Low 
Ommen  2011 
Injury or 
illness 
requiring 
hospitalizati
on, various 2197 
Secondary analysis of 
a cross-sectional, 
retrospective mailed 
survey study 
4-item scale 
measuring SDM 
as part of the 
larger CPQ Trust in physician 
SDM associated with trust in 
physician. 
3 
 
Moderate 
Glass 2012 Various 499 
Secondary analysis of 
a cross-sectional 
survey study 
9-item SDM-Q-9 
scale 
Satisfaction with 
decision 
SDM associated with satisfaction 
with the decision. 
4 
 
Moderate 
Johnson§ 2012 HIV 254 
Cross-sectional 
analysis from a 
longitudinal cohort 
study 
1-item variant of 
CPS 
Health care 
empowerment 
SDM is positively associated with 
health care empowerment. 
2 
 
Low 
Johnson§ 2012 HIV 148 
Cross-sectional 
analysis of a larger 
RCT 
1-item variant of 
CPS 
Health care 
empowerment No association. 
2 
 
Low 
Lim 2012 
Breast 
cancer 206 
Secondary analysis of 
a cross-sectional 
survey  
1-item variant of 
CPS 
Exercise, diet, stress 
management 
behaviors 
SDM is positively associated with 
engagement in exercise. 
 
No association between SDM and 
diet or stress management. 
2 
 
Low 
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Mo 2012 
Terminal 
cancer 93 
Cross-sectional 
survey 
2-item rating of 
involvement in 
decision making 
developed for 
this study 
Physical functioning; 
emotional functioning; 
quality of life; quality of 
death No associations. 
3 
 
Moderate 
Schleife 2012 
Breast 
cancer 107 
Cross-sectional 
survey 
1-item rating of 
involvement in 
decision making 
developed for 
this study 
Anxiety and 
depression; quality of 
life No associations. 
3 
 
Moderate 
Schoenthaler‡ 2012 Diabetes 608;41 
Cross-sectional 
mailed survey of 
patients and 
physicians and review 
of electronic health 
record 13-item PICS Medication adherence 
No association. 
 
In an additional analysis there was 
a significant interaction effect 
between social support and SDM 
so that the association between 
patient perceptions of SDM and 
medication adherence was 
stronger as social support 
increased. 
4 
 
Moderate 
Thum 2012 
Serious 
injury, 
various 91 
Cross-sectional 
analysis of a larger 
RCT 
3-item scale 
measuring SDM 
as part of the 
larger CPQ Trust in physician 
SDM associated with trust in 
physician. 
3 
 
Moderate 
Wallen 2012 
Rheumatic 
disease 109 
Cross-sectional 
survey study 
3-item rating of 
involvement in 
SDM as part of 
the larger 
Complementary 
and Alternative 
Medicine Use in 
Arthritis (I-
CAMP) 
questionnaire 
Use of complementary 
and alternative 
medicine (CAM); 
disclosure of use of 
CAM to provider 
SDM associated with use of CAM 
and disclosure of use of CAM to 
provider. 
2 
 
Low 
Clinician self-
reported SDM         
!! ''!
Heisler 2009 Diabetes 
4198; 
1217 
Cross-sectional 
mailed survey and 
medical record review 
1-item variant of 
CPS 
Satisfaction with 
provider 
communication; receipt 
of dilated eye exams; 
assessment of A1c; 
assessment of lipids; 
elevated A1c; elevated 
lipids; elevated systolic 
blood pressure No associations. 
4 
 
Moderate 
Schoenthaler‡ 2012 Diabetes 608;41 
Cross-sectional 
mailed survey of 
patients and 
physicians and review 
of electronic health 
record 
9-item Self-
Assessment 
Questionnaire Medication adherence No association. 
4 
 
Moderate 
Observer 
rated SDM         
Goossensen 2007 
Mental 
Illness 61;8 
Audio-recorded visits 
with post-consultation 
surveys 
OPTION scale 
(codes for 12 
physician 
communication 
behaviors), 
consultation 
was audio 
recorded and 
coded  
Satisfaction with 
involvement in 
decision No association. 
2  
 
Low 
Burton‡ 2010 
Heart 
disease 85 
Surveyed before and 
after consultation.  
Med students 
observed interaction 
and coded using 
OPTION scale 
OPTION scale, 
consultation 
was observed 
and coded 
Confidence in the 
decision No association. 
2 
 
Low 
Singh 2010 
Cancer, 
various 63 
Audio-recorded visits 
with pre- and post-
consultation surveys 
Coding system 
containing 20  
physician 
communication 
behaviors 
developed for 
this study 
Satisfaction with 
consultation; anxiety No associations. 
5 
 
High 
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Politi 2011 
Breast 
surgery - 
both 
prevention 
and cancer 
treatment  57 
Patient visits were 
observed and rated 
on the OPTION scale, 
patients completed 2 
surveys (immediately 
after consultation and 
1-2 weeks late via 
phone) 
OPTION scale, 
consultation 
was observed 
and coded 
1. Decision 
satisfaction; treatment 
decision consistent 
with recommendation 
from physician; 
aggressiveness of 
treatment chosen No associations. 
3 
 
Moderate 
Smith 
(Also Butow 
2010) 2011 
Breast 
cancer 55 
Audio-recorded visits 
with pre-consultation 
surveys and then 
follow up mailed 
surveys at 2 weeks 
and 4 months post-
consultation 
OPTION scale, 
consultation 
was audio 
recorded and 
coded  
Post-consultation 
anxiety; decisional 
conflict; satisfaction 
with the consultation; 
satisfaction with the 
physician's SDM skills; 
satisfaction with 
decision (after 2 
weeks); satisfaction 
with the decision (after 
4 months) 
SDM positively associated with 
satisfaction with the decision after 
4 months and satisfaction with the 
physician's SDM skills. 
 
No association between SDM and 
post-consultation anxiety, 
decisional conflict, satisfaction 
with the consultation, or 
satisfaction with decision after 2 
weeks. 
5 
 
High 
Langseth 2012 
Heart 
disease 49; 2 
Audio-recorded visits 
with post-consultation 
surveys 
OPTION scale, 
consultation 
was audio 
recorded and 
coded  
Treatment decision 
(invasive or non-
invasive) 
SDM associated with choice of 
non-invasive treatment. 
2 
 
Low 
 
* In two cases, the results from one study were published separately in two articles, but the patient outcomes evaluated as well as the measurement of SDM 
used overlapped entirely [Butow and Smith; Bleicher and Katz].  The results for each of these pairs of publications are considered only once in the context 
of this review. 
† Two publications [Clever and Swanson] are secondary analyses of the same sample, but use different measures of SDM modeled with different 
outcomes. Each unique SDM measurement and patient outcome assessment is listed separately here and throughout the review. 
‡ Two studies measured SDM from multiple perspectives.  Each unique SDM measurement and patient outcome assessment is listed separately here and 
throughout the review. 
§ Johnson et al., 2012 report the results from two separate studies in one publication.  Each study is listed separately here and throughout the review.
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Chapter 3: The complexities of understanding patient perceptions of shared decision 
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Abstract 
 
 
 
Introduction: Shared decision making (SDM) has been advocated as an optimal approach to 
making health care decisions, both on ethical grounds and increasingly as a means to improve 
patient outcomes.  However it is not clear how patients perceive SDM and what leads patients to 
label a decision as shared.    
 
Methods:  In-depth, qualitative interviews were conducted with 23 patients who recently 
attended a non-follow up primary care appointment.  Patients were asked about the meaning of 
SDM and about specific recent decisions that they labeled as shared.  Interviews were coded 
using a qualitative content analysis approach. 
 
Results:  Patients’ conceptual definition of SDM included four components of an interactive 
exchange prior to making the decision:  both doctor and patient share information, both actively 
listen to one another, patients advocate for themselves, and physicians make personalized 
recommendations.  Additionally, a long-term trusting relationship helps to foster SDM.  In 
contrast, when asked about why a specific, recent SDM was labeled as shared patients described 
interactions that ranged from very simple recommendations through complex interactions.  
Common among all decisions labeled as shared was that the patient and physician ultimately 
agreed on the decision.   
 
Conclusions: It seems there is no one-size-fits all process that leads patients to perceive a 
decision as being shared.  Rather, the outcome of “agreement” may be more important than the 
actual decision making process used to reach that agreement when patients label a recent 
decision as shared.     
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Introduction 
Increasingly, clinicians are being encouraged to employ a shared decision making (SDM) 
process with patients. Both the National Cancer Institute and the U.S. Preventive Services Task 
Force, among other organizations, have advocated for the use of SDM. 2,3 SDM has been 
suggested as an optimal approach to making health care decisions, 1 first on ethical grounds and 
increasingly as a means to improve patient outcomes. 97-99 
Despite this increasing attention, what exactly constitutes a shared decision making 
process is not always clear.  Among the academic literature, the most commonly cited definition 
of SDM is that developed by Charles and colleagues. 4,5 This definition includes four key 
characteristics, all of which must be present for a decision-making process to be labeled shared: 
at least two participants (patient and physician) are involved in all phases; both parties share 
information; both parties express treatment preferences; and agreement is reached. 5,100  But there 
are a variety of ways that SDM has been measured, including patient self-reports of having 
participated in SDM, physician self-reports, and structured coding of patient-physician 
communication. 11,101 Among these, only patient-self reports of SDM have been consistently 
associated with patient outcomes, including greater patient satisfaction, less decisional conflict, 
and medication adherence. 101  
Across studies, the most common way of measuring patient perceptions of SDM is using 
a modification of the Degner et al. (1997) Control Preferences Scale. 12,101 This scale asks 
patients to rate their role in making a specific decision among five choices: (1) I made the final 
decision, (2) I made the final decision after seriously considering my doctor’s opinion, (3) My 
doctor and I shared the responsibility for deciding, (4) My doctor made the final decision but 
!
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seriously considered my opinion, and (5) My doctor made the final decision.  Option 3 is 
typically considered a shared decision, and has been associated with patient outcomes including 
symptom improvement in primary care patients, 51 medication adherence, 52 and satisfaction with 
the consultation, 37 among others.  The single-item instrument for ascertaining patient 
perceptions of SDM leaves the process in a black box without out a clear understanding of what 
SDM means to patients.   
Furthermore, studies have repeatedly found that patient perceptions of shared decisions 
differ from both observer ratings of SDM, 19,94,102,103 and physician perceptions of SDM. 23,104 
Thus in order to attain the benefits of SDM in practice, a greater understanding of the patient 
perspective on SDM is needed.  We know of only two studies that have directly explored the 
meaning of SDM to patients. 21,22 While these studies highlighted important differences between 
patient perceptions of shared decision making and published definitions of SDM, they were not 
designed to understand what needs to have happened in a specific decision making context for a 
patient to label it as a shared decision. Thus, while it is known that patient reports of SDM are 
what drive the link between SDM and outcomes, 101 it is unclear whether patient perceptions of 
SDM about a specific, recent decision are related to their perceptions or ideals about SDM. 
The aims of this qualitative study are: (1) to develop a conceptual model of patient-
defined SDM, (2) to compare this conceptual definition with patient descriptions of a specific, 
decision-making process they labeled as shared on the modified Control Preference Scale and, 
(3) to contrast patient perceptions with Charles et al.’s theoretical model of SDM.  
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Methods 
Study setting and participant recruitment 
Participants were recruited from an academic and safety net health system in Virginia.  
The health system’s electronic scheduling system was queried to identify adults aged 50 to 75 
years with a non-follow-up primary care visit in the general internal medicine or family medicine 
out-patient clinic scheduled in the next month.  Among these age-eligible patients, the electronic 
medical record was queried for those who were due for colorectal cancer screening as specified 
by the U.S. Preventive Services Task Force. 24 These patients were mailed a letter of study 
introduction two weeks prior to their scheduled appointment.  Within one week after their 
scheduled appointment, patients who had not declined participation were contacted via telephone 
by the principal investigator (LAS).  At that time, eligibility was confirmed and among those 
eligible and agreeing to participate, verbal consent was obtained.  Recruitment continued until 
theoretical saturation was met. 105 All aspects of the study were approved by the Virginia 
Commonwealth University internal review board. 
Data collection 
  Study participation entailed completion of one telephone interview lasting approximately 
45 minutes.  The interviews were conducted by the principal investigator (LAS) using a semi-
structured interview guide. (See Box 3.1 for specific questions from the interview guide used in 
this analysis; see Appendix A for full interview guide.)  Participants were first asked to recall 
and describe any decisions made in their most recent primary care appointment.  They were then 
asked to indicate how the decision was made using the modified Control Preferences Scale, 12 
and to describe what during the visit led them to perceive that the decision was made this way. 
Following these questions, participants were asked about the meaning of SDM more broadly, 
!
!
! '(!
with the question, “Now, thinking more generally, this doesn’t have to be about your recent visit 
with [your doctor]:  What does the phrase “My doctor and I shared responsibility in deciding,” 
mean to you?”  Finally, participants were asked about their perceptions of the patient and 
physician responsibilities in a SDM process. All interviews were audio-recorded. 
 
Box 3.1:  Selected questions from semi-structured interview guide 
 
1. Let’s start by talking about some of the topics that you and Dr.__ discussed during your 
most recent visit.  Please tell me what topics you discussed. 
 
2. Were any decisions made about any of these topics?  Which ones? 
 
3. I’d like to hear more about the decision about <topic>?  How was that decision made? 
 
4. Now I am going to read you 5 choices for how the decision was made.  There are no right 
or wrong ways to make the decision, so none of these choices are better or worse.   
 
5. When it came to making the decision about <topic>, which of these would you say would 
best describe how the decision was made?  
 
a. I made the final decision.  
b. I made the final decision after seriously considering my doctor’s opinion. 
c. My doctor and I shared the responsibility for deciding.  
d. My doctor made the final decision after seriously considered my opinion. 
e. My doctor made the final decision. 
 
6. What makes you feel that the decision about <topic> was <type of decision chosen in 
Question 4>?  
 
a. What specific things happened during the visit that made you feel that <type of 
decision chosen in Q4>? 
b. What specific things did your doctor do or say that made you feel this way? 
c. What specific things did you do or say that made you feel this way? 
d. If someone were to have audio-recorded or video-recorded your visit with Dr. X, 
how would they have known from the audio or video that the decision was <type 
of decision choices in Q4>? 
 
7. Now, thinking more generally, this doesn’t have to be about your recent visit with Dr. X.  
What does the phrase “My doctor and I shared responsibility in deciding” mean to you?  
 
8. What things must you, as a patient, do during the conversation for you to consider a 
health care decision to be shared between you and the doctor? 
 
9. What things must the doctor do during the conversation for you to consider a health care 
decision to be shared between you and the doctor? 
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Data analysis 
Prior to analysis, all audio-recordings were transcribed. A qualitative content analysis 
approach was used to analyze interview data. Coding and analysis occurred concurrently with 
subsequent interviews and proceeded in three phases: immersion, reduction, and interpretation. 
106 During immersion, audio-recordings were listened to and transcripts read several times to 
identify emerging themes.  The reduction phase consisted of creating initial codes, developing a 
coding scheme, and coding the interviews using ATLAS.ti.  Coding consisted of both a priori 
codes informed by prior literature on SDM and inductive codes using the patients’ own words 
about SDM.  The principal investigator developed a preliminary coding scheme early in the 
analysis process and, in discussion with the coauthor, revised it using an iterative process as new 
relevant themes arose (see Appendix B for full list of codes). Once the conceptual model of 
patient-defined SDM was developed, the patient descriptions of decisions made during their 
recent primary care visit were coded with the same codes to allow for comparison of responses.  
The interpretation phase consisted of reorganizing the data into categories that help address the 
research questions and drawing conclusions from the data. 106 Memos were kept throughout the 
process to document the decisions made and help with interpretation. 105 
Results 
Sample characteristics 
A total of 60 patients were identified as potentially eligible, mailed a letter of study 
introduction, and called to assess willingness and eligibility.  Among these, 21 were not 
reachable by phone, 14 declined participation, and two wished to participate but were ineligible 
due to not attending their recently scheduled primary care visit.  In total, 23 patients were 
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interviewed.  Table 3.1 provides the characteristics of each patient in the sample.  Patient 
participants were primarily female (61%) and Caucasian (74%).  The mean participant age was 
63 years (SD = 10.4).  
 
Table 3.1:  Sample characteristics 
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Patients’ conceptual definition of shared decision making  
  When asked about the meaning of shared decision making in general, respondents 
described two key phases of SDM: an interactive exchange and making the decision.  The 
interactive exchange phase consisted of four interdependent components: sharing information, 
active listening, patient self-advocacy, and a personalized physician recommendation (Figure 
3.1).  Additionally, a cross-cutting theme emerged that spanned across the phases of SDM and, 
which patients describe as being essential:  the need for a trusting relationship that extends 
beyond a single encounter.   No differences were noted in patient conceptual definitions of SDM 
by patient age or race.  The following section describes these phases and related themes of 
patient perceptions of SDM. 
Phase 1: An interactive exchange 
 All patients described SDM as a collaborative process in which both the patient and 
physician are active participants. Patients described four iterative components that make up the 
interactive exchange phase of shared decision making: a mutual exchange of information, active 
listening, patient self-advocacy, and the physician making a personalized recommendation. 
Component 1:  Mutual exchange of information 
Patients nearly unanimously brought up the importance of a mutual exchange of 
information in which the patient shares any relevant concerns or problems and the physician 
shares medical and treatment information. This interactive information exchange process 
included “input from both sides” (Pt18).  Patients described specific roles for both themselves 
and for physicians in the exchange of information.   
First, patients are responsible to describe their symptoms and health concerns to their 
physician, so that their physician had the basic knowledge to begin forming a recommendation.  
!
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Figure 3.1:  Patients’ conceptual definition of SDM 
 
For example, one patient said, “They can’t read your mind.  If you don’t go in on your visit and 
tell them everything that’s going on for whatever your problem happens to be, they can’t really 
help you,” (Pt22).  Beyond simply describing symptoms, patients acknowledged a need to be 
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completely open with their physician about anything that might affect their health, even if the 
topic is uncomfortable.   Many patients brought up the concept of “honesty”, noting its 
importance in reaching the best possible decision.  One patient described this with, “The patient 
needs to have shared everything that's going on that might possibly be contributory to whatever's 
happening, whether that's casual drug use or whatever… I think you'd have to have made the 
decision to be open and honest with the physician,” (Pt17).  Another said, “You (need to) be 
honest with the doctor.  Just like a priest.  You can tell the doctor everything.  And you should, 
because they cannot treat you to your best advantage if they don't know everything.” (Pt 8) 
Patients acknowledged that physicians also have the responsibility to share information.  
Specifically, according to patients, physicians should share any relevant medical information and 
treatment options, taking the time to clearly explain in language that is understandable to 
patients.  One patient described this, saying that it is important, “that your doctor tell you what’s 
going’ on, explain your options to you,” (Pt13).  Another described the importance of the 
physician taking the time, “to explain what I had, to explain the medication.  So, I knew exactly 
what it was for, how to use it,” (Pt 10). 
Component 2:  Active listening by both parties  
In addition to sharing information, many patients specifically described listening as an 
important component of SDM. Patients were clear in their beliefs that both physicians and 
patients bring their own specific expertise to the interaction.  Physicians bring medical expertise 
and training while patients have unique knowledge about their own body and symptoms. Thus, 
acknowledging the physician’s medical expertise, patients stated that they should listen and be-
open minded about what the physician says. 
“I have to be very open and honest to her and I also have to be open minded enough, and 
I know that this is hard sometimes for me, open minded enough that if she recommends 
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something that's a little unusual that I really need to seriously consider that because I 
know she's doing what she feels is best for me.” (Pt8) 
 
Likewise, patients stated that physicians should also take the time to listen to and 
understand patients.  This takes the form of an interactive conversation rather than the physician 
simply providing medical information.  Patients described two ways that they understood 
physicians to be listening to them.  First, when a physician makes time to talk with a patient on a 
more personal level, this helps the patient to be assured that the physician sees them as an 
individual person with unique circumstances and needs.  Patients desired to see this type of 
active listening throughout the visit, not only during the discussion about the particular decision 
at hand. 
“I think they just have to be very open and not rush and talk so fast and talk in ‘doctor-
ese’ that you don't understand them-that if they can just look at you and-like you're a 
person and not patient number 93.” (Pt15) 
 
Second, patients wanted physicians to respect the expertise that they bring to the visit.  To do 
this, physicians should carefully listen to patients, solicit their thoughts and concerns, and take 
time to answer questions before forming a recommendation.   
“The doctor has the training and the knowledge and everything, but I feel that the doctor 
needs to listen to the patient, listen to what they’re saying.  The doctor sees you for half 
hour, 15 minute appointments or whatever… you live with yourself” (Pt2) 
 
Component 3:  Patient self-advocacy 
Patients described a responsibility to advocate for themselves throughout the SDM 
process.  This may consist of asking questions if clarification is needed, guiding the conversation 
if the physician gets off track, sharing opinions, and speaking up if there are hesitations or 
disagreements. As one patient stated, “if you don’t feel right about something; don’t be afraid to 
challenge that doctor to get the information that you really want to have,” (Pt 4).  Similarly, 
another said, “If you have a doubt, talk about it.  Be prepared with questions.  If it's something 
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serious, have your questions down.  Don't be afraid,” (Pt7).   Like active listening, patients 
described the importance of these self-advocacy behaviors not only during the decision-making 
process, but also extending to all parts of the visit.  By engaging in this way, patients viewed 
themselves as actively contributing to the formation of the best possible decision. 
Component 4:  Physician makes a personalized recommendation 
Most patients seemed to take it for granted that physicians should provide a 
recommendation for action, whether for treatment or no treatment, during the discussion.  
However, they had specific thoughts about how these recommendations should be made.  First, 
patients wanted to feel the physician knew and understood them before making the 
recommendation.  As one patient put it, “I don't want doctors telling me what's best for me 
without me knowing that they understand what's best for me from my point of view,” (Pt7). 
In order for patients to feel confident that these recommendations are based on the 
individual patient and their unique situation, rather than relying only on what the physician 
typically recommends, patients reported that physicians must take the time to explain the 
reasoning behind their recommendations.  For example, one patient said they’d like physicians to 
“explain the reason for a certain procedure or an appointment with a specialist or whatever.  It’s 
helpful to me, and I think it would be for most patients, to understand why something is being 
suggested,” (Pt 12).   Patients want to understand both the benefits of the treatment or procedure 
in general as well as why it is specifically recommended for them.  Additionally, the words that 
physicians use to make the recommendations to patients affect patients’ perceptions of SDM. 
Patients stated that they want physicians to make suggestions or give options, not demands or 
ultimatums.  One patient gave an example of how this type of personalized recommendation 
might play out in practice: 
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“The doctor has to be willing to defer somewhat what might be convenient for him or 
something that he’s more comfortable doing… I just think there has to be a lot of 
interaction and dialog rather than just dictating orders to patients.  Like we’re going to 
put you in the hospital tomorrow and we’re going to do this and we’re going to do that.  
Let’s slow down here a minute and let’s talk about this.  How about if I put this off for a 
month?  What’s the consequence of doing that?  How about we don’t put me in the 
hospital at all?  The patient’s got to be active.  Being active, the doctor’s got to be 
receptive to that and willing to work-willing to take the time that’s necessary to explain if 
he has strong views about why that idea is the best one.”(Pt14) 
 
Phase 2: Making the decision 
Following the collaborative exchange between the patient and physician in which 
information was shared and a personalized recommendation was provided, patients then said that 
a decision is made that is in the best interest of the patient.  Patients generally described one of 
two perspectives about how the decision was made.  About half of the patients (n=11) described 
decision making as mutual between the patient and physician.  One patient described the 
decision-making process with, “You and your doctor talk over all the options and come up with a 
shared thought about what’s the right way to do it,” (Pt1).   Another said, “Well, for me that 
means that we thoroughly talk about any issues, concerns that I have and he has, and that we 
come to some agreement around treatment or non-treatment or whatever we're going to do.” 
(Pt6) 
The other half of patients (n=12), however, stated that ultimately the patient always 
decides, even in a SDM process.  These patients acknowledged that the patient has to take final 
responsibility, even if they shared in the communication process leading to the decision.  One 
patient said, “It’s a collaborative thing, but I mean I clearly feel that it’s my decision.  I also 
assume that my doctors share that assumption… but yeah I’m the decision maker” (Pt16).  
Another patient described the distinction between a shared process and the final decision with, 
“I’m thinking sharing, that’s the way it should be.  I mean they can give you their 
opinion, but it’s something that you’ve got to live with.  I mean, I know you’re going to 
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them because they went to school for many years or whatever, but ultimately it’s still 
your life and your body.” (Pt20) 
 
Crosscutting Theme: Trusting relationship built over time 
Patients also pointed to the importance of a strong rapport when describing SDM.  
Prominent among this was the need for the patient to trust that the physician knows them and 
understands their health care needs and preferences.  As described by patients, the building of 
this trust is not confined to the communication around a particular decision itself, but is built 
over time and extends beyond a single visit. As one patient stated,  
I think you just have to find a doctor you trust, not because he's the best doctor out there 
and somebody else recommended him.  That's nice, but what's the sense of having the 
best doctor out there if you don't have trust in him and you can't talk to them, you know? 
(Pt 7) 
 
A trusting relationship allows for both patient and physician to feel comfortable throughout the 
collaborative exchange to speak up if they are uncomfortable, and for a high quality, 
personalized decision to be made.  One patient described how this trusting relationship with his 
physician helps him to make high quality decisions. 
It's wonderful that I have a strong relationship with [my doctor] because I think those are 
the kinds of relationships that are hard to come by these days in medical care.  I think he's 
especially good at making sure that I'm comfortable with decisions.  There have been 
occasions where he's sensed that I have some concerns, and he's gone ahead and referred 
me when I suspect that he's been fairly sure about his decisions, but he wants to make 
certain that I'm comfortable, and he's comfortable too. (Pt6) 
 
Decision-making processes that patient label as shared 
Patients were also asked to describe any decisions that they made in their recent primary 
care appointment.  A total of 33 unique decisions were described across the 23 interviews.  The 
reported number of decisions made during the recent primary care visit ranged from zero to 
three, with a median of one decision per visit.  The context of the decisions was varied and 
included decisions about adding or changing medications (n=11), ordering diagnostic tests (n= 
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9), referrals to specialists (n=5), cancer screening (n=4), ordering “routine” blood work (n=2), 
prescribing a vaccine (n=1), or changing health behaviors (n=1).  Of these 33 decisions, 15 
(45%) were reported as being shared decisions on the modified Control Preference Scale 12 
(option 3), 13 (40%) were reported as patient-led decisions (option 1 or 2), and 5 (15%) 
physician-led decisions (option 4 or 5).  
Across the 15 decisions that patients labeled as shared, the level of communication 
between the patient and physician described by patients as having occurred varied greatly, 
ranging from extremely short and simple exchanges to lengthy discussions.   The only 
commonality found across the 15 decisions that patients labeled shared was that the patient and 
physician ultimately came to an agreement. Further analysis revealed three general patterns of 
communication: simple agreement by the patient to a physician recommendation, patient 
pushback to a physician recommendation, and a patient-led recommendation.  In this section we 
apply the phases and themes of patients’ conceptual definition of SDM to the patient descriptions 
of the specific decisions that they labeled as shared within each of the three general patterns of 
communication.   
For a third of the decisions labeled as shared (n=5), patients described a straightforward 
process in which their physician made a recommendation and the patient simply agreed.  In this 
situation, very little communication exchange seemed necessary to consider the decision to be 
shared.  In these cases of simple agreement, the only component of the patient conceptual 
definition of SDM that was reported was a physician recommendation.  However, even these 
recommendations did not meet the full requirements of a personalized recommendation where 
the physician explained both why the procedure is suggested in general and for the individual 
patient in particular.  Rather, patients described very straightforward recommendations without 
!
!
! @)!
an active exchange of information.  Below are two of these patient descriptions of decisions 
labeled as shared that included only simple interactions: 
“She just said, if I hadn’t had [a bone density scan] in three years, and I said, oh, I know 
it’d been longer than three years.  She said, “Well then I think you should have one,” and 
I said fine.  That’s fine with me.  So that’s a shared… She didn’t say to me, you have to 
have this.  I mean, you know, we discussed it, and we both agreed.  So that’s shared.” 
(Pt1) 
 
“She said I would suggest as long as you fasted, you might as well take it [blood work for 
liver function] if you want.  And so she was-and then when I said yes, she said that's a 
good idea.  To me, I felt it was a mutual thing.  I could have said, well, nah, let's wait 
until next six months and-but she said you might as well do it now.” (Pt15) 
 
In other cases, a physician made a recommendation and the patient had questions or 
hesitation (n=6; 40%).  After discussion, the two parties ultimately came to agreement, and this 
was also labeled as a SDM process.  In this situation, patients described various levels of 
interaction that ranged from simple questions and recommendations to much more detailed 
discussions.  These decisions most closely resembled the conceptual model of patient-defined 
SDM.  That is, patients described some exchange of information, active listening on the part of 
the physician, patient self-advocacy (including questions of clarification, expressing differing 
opinions, and soliciting the physician’s opinion about alternative options), and all contained a 
physician recommendation. For example, one patient described the decision with the following: 
“He said, given your history, I might like to consider medication [to lower cholesterol]… 
I felt that, at this point, I really don't want to take another medicine.  I would like to try 
other methods before even considering going on medication… He listened to what I felt, 
my point of view or whatever.  It wasn't a snap judgment, ‘Okay, your cholesterol is up 
and you're going to go on medication, and that's that.’  He listened and after discussion, 
and I said that I was reluctant to take medication at this time.  He agreed, ‘Okay, we can 
wait and see how the other methods are working.’” (Pt2) 
 
 The third type of shared decision described by patients involved a patient bringing in a 
specific request for the physician (n=4; 27%).  These situations differed from the conceptual 
SDM process described by patients, because the patient was the party who made the initial 
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recommendation.  The communication process after the patient recommendation was typically 
described as being similar to those in the first category who had simple agreement with their 
physician.  That is, very little communication exchange seemed to be necessary to label these 
decisions as shared. 
“Well, I just I brought it up. I had been in my local pharmacy a couple months ago and I 
saw they were offering [the shingles vaccine] there… I’d had two scary incidents with 
shingles over the course of the last 20 years; both involving it appearing in my scalp and 
near my eyes.  I wanted to-I’m very interested in getting that preventive vaccine so I 
don’t have another outbreak of it…He said, ‘I’ll be happy to write that prescription for 
you.’  I said, ‘Good, let’s give it a shot.’…I wanted to get it and he thought I needed it so 
it was a pretty mutual decision.” (Pt14). 
 
Across all three of these interaction types, when asked about why a recent, specific 
decision was labeled as shared, the concept of a relationship of trust did not arise explicitly in the 
way that it did when patients described the process of SDM in general.  Only one patient directly 
addressed trust when asked about why a specific decision was perceived as shared.   
“She (was) sharing with me the medical complications of taking it or not taking it.  I'm 
sharing with her some of the things that I know that might have influenced it.  It's a give 
and take.  I think both of us, if you would've heard that, it would've sounded like we were 
both being respectful of each other…Anyway, it has to do with trust that the other one is 
genuine-that we were jointly doing this.  It's a trust issue, and I think you could hear that 
in the conversation.” (Pt 17). 
 
However, for most patients, particularly those who described an interaction characterized by 
simple agreement with the physician, trust was not mentioned.  In these conversations, however, 
the manner in which the patients described themselves as easily agreeing with physician 
recommendations implies some level of trust in the physician’s medical opinions (see 
descriptions of decisions above).    
In summary, despite the diversity of interactions labeled as shared, two important 
commonalities existed.  First, except where a patient brought in their own specific request for the 
physician, all discussions that patients labeled as shared included a physician recommendation 
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for treatment or non-treatment.  Second, all patient-perceived shared decisions ended in 
agreement between the patient and physician.  Furthermore, in the cases labeled as shared 
decisions where patients agreed quickly with the physician’s recommendation, very little 
communication process at all was described.  Thus, patient perceptions of having participated in 
a shared decision may be more about the outcome of agreement with a physician 
recommendation rather than any specific communication process. 
Patient perceptions of SDM compared to Charles et al.’s theoretical model of SDM  
When asked about the meaning of SDM in general, patients describe an interactive 
communication process that is similar to the commonly used definition of SDM developed by 
Charles and colleagues (1997, 1999).  My findings point to the importance of active participation 
and a mutual exchange of information (see Table 3.2).  However, in the hypothetical at least, 
patients state that they want physicians to listen if they have a treatment preference to express, 
but that expressing a preference is not a necessary component of SDM.  Similarly, patients 
acknowledge that there are times when they may participate in a SDM process but ultimately not 
agree on the decision.  Thus, patients’ conceptual definition of SDM does not support the 
necessity of characteristics 3 and 4 (both participants sharing their treatment preferences and 
reaching agreement around the decision) in the Charles et al. definition in order for a decision to 
be considered shared.  In contrast, when patients are asked to describe a specific, recent shared 
decision, there was no consensus about the specific communication content needed for a decision 
to be considered shared.  Rather, patients focused on their agreement with a physician 
recommendation (Charles et al. characteristic 4). 
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Table 3.2:  Comparison of patient conceptual definition of SDM to patient experiences with 
a recent shared decision and a theoretical definition of SDM 
 
 Charles et al (1997, 1999) 
Patient 
conceptual 
definition of SDM 
Patient experiences with 
a recent, specific decision 
labeled as shared 
Characteristics from Charles et al.    
Both patient and physician are 
actively involved !  !   
Both patient and physician share 
information  !  !   
Both patient and physician share 
treatment preferences !    
Both patient and physician reach an 
agreement on decision !   !  
New communication components    
Both patient and physician actively 
listen to one another   !   
Patient advocates for self throughout 
the visit  !   
Physician makes a personalized 
recommendation  !   
Rapport extending beyond a single 
encounter  !   
 
In addition to these communication components, these findings contribute several new 
themes to patient definitions of SDM.  First, when asked about their conceptual definition of 
SDM, patients described a desire for care that is tailored to the individual patient in their specific 
circumstances.  In order to accomplish this, patients want to feel that the physician understands 
their individual needs and opinions and has used this understanding when making a 
recommendation among various medical options.  They emphasized the importance of both 
patient and physician actively listening to one another and being open-minded to 
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recommendations outside of what they might be accustomed to doing if it is in the best interest 
of the individual patient.  Second, patients described an important aspect of their role in SDM to 
be advocating for themselves.  Self-advocacy includes such responsibilities as being prepared for 
the visit, asking hard questions, speaking up if there is hesitation, and ultimately asking for a 
second opinion if desired. Finally, in order for both personalized care and patient self-advocacy 
to be possible, patients in our study also described the importance of a trusting relationship that 
is built over time, and extends beyond a single encounter.   
Discussion 
Patient perceptions of the meaning of shared decision making about a recent, specific 
decision differ from their conceptual definition of SDM.  When asked about SDM in general, 
patients described two phases: an interactive exchange and making a decision.  The interactive 
exchange is a collaborative process that includes four interdependent components: sharing of 
information, active listening, patient self-advocacy, and a personalized physician 
recommendation.  On the other hand, when patients labeled a recent, specific decision as being 
shared, they described a variety of communication processes ranging from simple agreement 
with little or no discussion, through a more interactive process similar to that which would be 
labeled as SDM using currently accepted definitions.  Common across all decisions perceived as 
shared was ultimate agreement between the patient and physician.  Thus, while patient 
conceptual definitions of SDM center around interactive communication processes, patient 
perceptions of having participated in a shared decision may be more related to the outcome of 
agreement with a physician recommendation rather than any specific communication process 
that led to this agreement. 
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  These findings have implications for both the measurement of SDM as well as 
intervention design.  Results from my interviews indicate that SDM, when measured by 
instruments such as the modified Control Preference Scale, likely does not reflect patient 
perceptions about the communication process itself.  Thus, if the purpose of a study is to 
understand patient’s perceptions of a communication process, the modified Control Preference 
Scale may not be an appropriate tool.  Degner’s Control Preference Scale was designed to 
measure preferences for level of involvement in decision-making rather than perceptions about 
what actually occurred. 12 Although it is widely used in its modified form to measure perceptions 
of involvement, my findings indicate that it may not measure this concept well. 
My findings also have implications for the measurement of SDM beyond a patient’s 
perspective.  In these interviews, patients described their own role in the information exchange 
and decision-making as being as active as or more active than the physician role.  However, 
many of the most commonly used measurement tools for SDM (including the OPTION scale 9) 
focus solely on physician behaviors and thus may be missing important aspects of the 
interaction. Similar to other recent qualitative studies, 21,22 my findings point to the importance of 
relational factors within the visit on patient perceptions of SDM.  However, patients in this study 
also emphasized the importance of relational factors beyond the current visit and described the 
importance of a trust between the patient and physician that is built over time. Thus, findings 
from this study provide support for others who have called for the measurement of SDM as part 
of a larger interaction and relationship rather than focus solely on the discussion specific to the 
current decision. 107 
  In interviews, patients spoke of the importance of advocating for oneself in order to fully 
participate in a SDM process.  Thus there may be a need for interventions that encourage patient 
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self-advocacy such as asking questions, speaking up when uncomfortable, or asking for a second 
opinion.  Past studies have shown that when patients are more active in their consultations, 
physicians both share more information 108 and adopt a more patient-centered style of 
communication. 109  Interventions to promote patient participation and self-advocacy could 
include communication training for either the patient or the physician.  Patient interventions 
might include communication training that builds skills on assertiveness and question-asking.  
Physician interventions could provide training around creating a trusting environment that would 
allow patients to feel comfortable speaking up.   
There are several potential explanations for my finding that patient reports of SDM about 
a specific, recent decision seem to be more about the outcome of agreement than the 
communication process experienced.  First, it is plausible that the wording of the choices 
themselves, led patients to think of an outcome rather than a process.  In these interviews I used 
the modified Control Preference Scale, which asks patients to respond to the following question: 
“When it came to making the decision about <the specific topic>, which of these would you say 
would best describe how the decision was made?”  The option that represents SDM is, “My 
doctor and I shared responsibility for deciding.”  “Shared” in this context may be more about 
shared agreement rather than a detailed collaborative (shared) process.  Furthermore, if patients 
have an expectation that they will talk respectfully with their physician and come to agreement 
on a plan, and this expectation is met, patients are not likely to consider the process that led to 
the accomplished goal. This makes sense in light of communication theory, such as Expectancy 
Violations Theory, 110 which posits that when a person’s expectations of the interaction are 
violated, their focus changes from the original purpose of the interaction (agreement on a 
treatment plan) to thinking about the source of the discrepancy (or the communication process 
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itself).  Thus, unless a patient’s implicit expectation is violated with extremely poor or 
disrespectful communication, the patient is not likely to think about the communication process 
itself, but rather stay focused on the goals of the consultation.    
Despite past studies indicating that differences in preferences for level of involvement 
and reports of participating in SDM by age 111,112 (Frosh & Kaplan, 1999; Levinson et al., 2004) 
and race, 113,114 my study did not find any differences in patient perceptions of the meaning SDM 
by age or race.  This may indicate that age and racial differences in reports of shared decisions 
lie in actual differences in occurrence rather than in differences in the way patients define SDM.  
  This study has several potential limitations.  Patients described a diverse array of topics 
for which decisions were made during their primary care visits.  The small sample size, while 
appropriate for the aims of the qualitative study, did not allow me to examine perceptions by the 
context of the decision or the existing relationship the patient has with the physician seen. Thus I 
do not know whether patient perceptions of what constitutes a shared decision might vary by 
decision context.  Second, I sampled patients who had recently attended a non-follow up primary 
care appointment.  Thus, this sample may represent patients who are more active in their 
healthcare and perceptions of SDM may differ for those who take a less active approach.  
Finally, while we did not find any difference in patient perceptions of SDM by age or race, we 
did not have access to their level of educational attainment.  Future studies may want to explore 
whether level of education affects how patients perceive SDM in both conceptually and 
regarding a specific, recent decision.    
Conclusion 
 Patient reports of making a shared decision have been linked with improved patient 
outcomes. 101 However in order to foster the communication linked with these outcomes in 
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practice, a clear understanding of what leads a patient to label a decision as shared is needed.  
This study makes an important contribution to the SDM literature by focusing specifically on the 
patient perspective of SDM.  While SDM is often advocated on ethical grounds as a means to 
improve patient autonomy, the voice of the patient is notably lacking in most studies.  The results 
presented here help to bridge this gap and allow for a better understanding of how patients 
conceptually define SDM as well what leads them to label a decision as shared.  My findings 
indicate that patients have a clear idea of how they define SDM in general.  Conceptually, 
patients describe a SDM process similar to accepted models of SDM in the literature, but with a 
greater emphasis on active listening and relational factors that are influenced by a relationship 
built over time.   However, in the context of a specific, recent primary care decision, when 
agreement is reached about the decision, patients may perceive even relatively simple 
interactions as being shared decisions.  Thus, it seems there is no one-size-fits all process that 
leads patients to perceive a decision as being shared.  Rather, the outcome of “agreement” may 
be more important than the actual decision making process used to reach that agreement when 
patients label a recent decision as shared.     
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Abstract 
 
 
 
Introduction: The U.S. Preventive Services Task Force advises that physicians use a shared 
decision making (SDM) process when recommending preventive services, such as colorectal 
cancers screening. The aim of this study is to determine whether the occurrence of the four 
components of patient-defined SDM (exchange of information, physician active listening, patient 
self-advocacy, and a personalized physician recommendation) are associated with adherence to 
physician-recommended colorectal cancer screening, and whether this relationship is moderated 
by the patient’s initial verbal response to the physician recommendation.   
 
Methods:  Secondary analysis of a dataset of 410 audio-recordings of primary care visits that 
included a physician recommendation for colorectal cancer screening.  Audio-recordings were 
coded for the four components of patient-defined SDM as well as the patient’s initial verbal 
response to the recommendation.  Colorectal cancer screening use in the following year was 
available via electronic medical records.  
 
Results:  The most commonly observed component of patient-defined SDM was patient self-
advocacy (76%), followed by physician exchange of information (61%), physician active 
listening (60%), and a personalized physician recommendation (23%).  Only 35 visits (9%) 
contained all four patient-defined SDM components.  In adjusted models, physician provision of 
information around the process and potential side effects of colorectal cancer screening was 
associated with an increase in screening. Patients who initially refused were least likely to be 
screened (40%), while patients who did not verbalize a response to the recommendation were 
most likely to be screened (70%).  The screening rate among patients who initially verbally 
agreed with the recommendation was not different than the overall screening rate (49% vs. 55%).   
 
Discussion: My findings point to the importance of providing all patients with information 
alongside a recommendation for colorectal cancer screening.  Even patients who initially agree to 
recommendations may have questions or concerns that would benefit from an interactive 
discussion. 
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Introduction 
In the United States, colorectal cancer is the third leading cause of cancer death for both 
men and women.  Despite being a preventable cancer if polyps are discovered and removed 
early, approximately 40% of people for whom screening is recommended remain unscreened. 25 
Having a physician recommendation for screening is one of the best predictors of colorectal 
cancer screening (CRCS) use. 115 When making these types of preventive service 
recommendations, the U.S. Preventive Services Task Force (USPSTF) advises that physicians 
use a shared decision making (SDM) process. Patients who report good communication with 
their physician, including involvement in shared decision making, are more likely to be adherent 
to colorectal cancer screening recommendations. 34 
Until recently it was not clear what patients actually meant when they endorsed a 
decision as being shared, making it difficult to advocate for specific communication practices 
that promote adherence to colorectal cancer screening.  Results from three recent qualitative 
studies, however, enable a better understanding of the communication processes that patients 
label as “shared”. 21,22,116 Collectively these studies find that patients value an interactive process 
in which the patient and physician share information and through which the patient feels listened 
to and understood before making a medical decision.  Furthermore, the results from Shay (2013) 
highlight differences in the way patients define SDM by a patient’s initial level of agreement 
with the physician’s recommendation. 116 That is, when a patient agrees with a physician’s 
recommendation, a less complex interaction may be needed for the patient to perceive the 
decision as shared relative to when the patient initially disagrees or has some hesitancy towards 
the physician’s recommendation.  Thus to promote adherence to physician-recommended 
colorectal cancer screening in practice, it may be important to understand not only which specific 
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patient-physician communication components effect screening use, but whether the impact of 
these components differs by the patient’s initial reaction to the colorectal cancer screening 
recommendation.   
The current study uses the model of patient-defined SDM developed by Shay (2013) to 
determine whether and which components of SDM are associated with adherence to physician-
recommended colorectal cancer screening and whether the relationship between these 
components and adherence to colorectal cancer screening is moderated by the patient’s initial 
reaction to the physician recommendation.  
Methods 
Conceptual framework 
The conceptual framework informing the study design and variable selection was adapted 
from two existing models (Figure 4.1).  The Communication Model of SDM posits that 
patient/provider communication is transactional, involving two engaged participants, and 
acknowledges that decisions are influenced by both pre-existing individual patient and physician 
characteristics and the communication climate in which the decision takes place. 117 Second, the 
model of patient-defined SDM developed by Shay (2013) involves an interactive exchange 
between the patient and physician that is made up of four interdependent components: physician 
exchange of information specific to the decision at hand, physician active listening throughout 
the visit, patient self-advocacy throughout the visit, and personalized physician recommendation.  
Data Sources 
Data for the current analysis come from an observational study of patient-physician 
communication in the context of colorectal cancer screening. 19,103,118 For that study, 64 primary 
care physicians and 500 of their patients in an integrated health system in southeast Michigan  
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Figure 4.1 Conceptual framework adapted from Siminoff & Step (2005) and Shay (2013) 
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were enrolled between February 2007 and 2009.  Eligible physicians included salaried family 
and internal medicine physicians on staff with a large integrated health system.  Eligible patients 
were aged 50 to 80 years, insured via the health system affiliated HMO, and due for colorectal 
screening at the time of their scheduled period health exam with a study participating physician. 
Details of the recruitment and enrollment processes have been published elsewhere. 19,103,118  
Data were collected via pre-visit patient surveys, audio-recordings of the office visits, 
health system records, and the electronic medical record.  Research assistants administered pre-
visit surveys via the telephone at the time of recruitment that included measures of socio-
demographic characteristics, patient preferences for role in decision-making, and patient 
perceptions of their physician (among those who had previously seen the same physician).  
Patient and physician communication during the office visit was captured via a small digital 
recording device.  All audio-recordings were transcribed prior to coding.   Physician 
characteristics, including age, gender, race, and medical specialty (family or general internal 
medicine) were obtained from health system records.  All aspects of the current research protocol 
were approved by Virginia Commonwealth University’s Institutional Review Board. 
Dependent variable: adherence to physician-recommended colorectal cancer screening 
The primary outcome in this study is adherence to physician-recommended colorectal 
cancer screening in the 12 months following the audio-recorded visit.  Screening use was 
identified via service codes in the electronic medical record for all screening modalities that were 
recommended by the USPSTF at the time of the study, including fecal occult blood test, 
colonoscopy, flexible sigmoidoscopy, or double contrast barium enema. 24 Patients were 
considered to have been adherent to physician-recommended colorectal cancer screening if, per 
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the electronic medical record, they received at least one of these procedures in the year following 
their recorded visit. 
Explanatory variables: patient-defined SDM and patient’s initial reaction to colorectal 
cancer screening recommendation 
For this study I am primarily interested in how the components of patient-defined SDM 
are associated with adherence to physician-recommended colorectal cancer screening and how 
these associations might be moderated by the patient’s initial response to a physician 
recommendation for screening.  Thus, each of the visit transcripts was coded for the four 
components of patient-defined SDM (as depicted in Figure 4.1) and for the patient’s first verbal 
indication of their response to a recommendation for colorectal cancer screening.   
Each of the components of patient-defined SDM was coded as either present or absent.  
Physician sharing of information was coded present if the physician provided information about 
the process or side effects of any of the four recommended colorectal cancer screening 
modalities (colonoscopy, sigmoidoscopy, fecal occult blood test, or barium enema).  Physicians 
were considered to have used active listening if they responded to patient comments using 
prompted partnership building or supportive. 119 Patient self-advocacy behaviors included asking 
questions, expressing concerns, or using assertive responses. 119 Physicians were considered to 
have given a personalized recommendation, if he or she provided both general reasoning as to 
why colorectal cancer screening is recommended (e.g., early detection, removal of polyps, 
disease is asymptomatic, etc.) and a verbal assessment of the individual patient's eligibility for 
screening (i.e., due to age, family history, length of time since last screening, or a reference to 
the electronic medical record).   
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Additionally, each transcript was coded for the patient’s initial verbal response to the 
physician’s initial recommendation for colorectal cancer screening.  Responses were coded as 
either: agreement; hesitation; refusal; or no verbal response.  Patients who initially agreed were 
those who brought up the topic of colorectal cancer screening themselves, volunteered 
willingness, or answered affirmatively when asked directly about their willingness to be screened 
(e.g. “I will.  I’m going to do it,” or “Oh I know I should.”).  Patient responses that were coded 
as hesitant were those in which the patient’s first reaction was to ask questions about the 
screening (e.g. questions about pain, sedation, need for screening) or those that expressed a 
barrier to or concern about screening (e.g. “I don’t have a ride,” or “My mother had it and it was 
very painful.”).  Initial refusal was coded when a patient volunteered their unwillingness to be 
screened or who answered in the negative when asked directly about willingness to be screened 
(e.g. “I just don’t want to do it.” or “I feel that I’m healthy and don’t need it.”).  Finally, some 
patients did not provide a verbal response to the physician recommendation, or only responded 
using noncommittal language such as “mm hmm” or “uh huh”.  These were coded as no verbal 
response.  
 Coding for the communication elements that made up the four components of patient-
defined SDM was done as part of the parent study. 19,103,118 Interrater reliability for these 
variables was measured with Cohen’s Kappa and ranged from 0.56 to 1.00.  Patient’s initial 
response to the recommendation was coded specifically for the current study;  the principal 
investigator (LAS) conducted this coding. Interrater reliability was assessed by having a random 
selection of 10% of the recordings (n=41) coded by a research assistant.  Cohen’s Kappa for 
patient initial response category was 0.74. 
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Control variables: patient characteristics, physician characteristics, and communication 
climate factors 
The choice of control variables was influenced by my conceptual framework (Figure 4.1). 
Pre-existing patient and physician characteristics included patient and physician age, gender, and 
race (black, white, and other) as well as patient educational attainment (less than a high school 
diploma, high school diploma, some college, college degree or more) and physician specialty 
(general internal medicine and family medicine).  Pre-existing communication climate factors 
included patient preference for level of involvement in cancer screening decisions, 12 non-
adherence to a previous recommendation for colorectal cancer screening, patient self-reported 
health status, 120 patient reported depressive symptoms, 121 and patient reports of trust in their 
physician prior to the recorded visit. 122 
Statistical analysis 
Data were first considered descriptively.  Unadjusted logistic regression was used to 
determine whether there were differences in the occurrence of the four patient-defined SDM 
components by patient initial response to a physician recommendation for colorectal cancer 
screening.  Next, simple logistic regression models were used to evaluate whether each of the 
components of patient-defined SDM was associated with colorectal cancer screening use and 
whether screening use differed by the patient’s initial response to a screening recommendation.  
A multiple logistic regression model was then fit to determine the relationship between 
colorectal cancer screening receipt, and the components of patient-defined SDM and the 
patient’s initial response to screening controlling for pre-existing patient and physician 
characteristics and communication climate factors.  Finally, interaction terms were added to test 
whether the patient’s initial response to a screening recommendation moderated the effect of the 
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components of patient-defined SDM on colorectal cancer screening use. Effects coding, or mean 
deviant coding, was used in modeling the categorical predictor variables.  In contrast to standard 
dummy coding, effects coding allows for assessment of the true main effects in models that 
include multiple categorical predictors or interaction terms, 123,124 and for the comparison of each 
subset of the data to the overall mean (i.e. average screening rate). 123,125 All models were fit in 
MPlus with a logistic fit function using all available data.  Standard error estimates that corrected 
for the non-independence of observations were attained during estimation for all analyses to 
control for the clustering of patients by physician.   
Results 
Sample characteristics 
 A total of 500 patients consented to participate in the parent study.  Ninety of these cases 
were excluded from the current analysis for the following reasons: missing or inaudible audio 
recording (n=15); no discussion relating to colorectal cancer screening (n=29); already had 
screening scheduled at the time of the recorded visit (n=29); office visit discussion indicated 
patient not due for screening (n=12); pre-survey data was not available (n=3); screening only 
discussed in the context of an ongoing workup for symptoms (n=1); or physician did not 
recommend colorectal cancer screening due to current diagnosis of lung cancer (n=1).  Thus, the 
sample for the current analysis includes 410 patient visits among 64 physicians.  Pre-existing 
patient and physician characteristics and communication climate factors are depicted in Table 
4.1.   
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Table 4.1 Pre-existing patient, physician, and communication climate characteristics 
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•  Patient health status was measured in a pre-visit survey with the question, “In general how would you rate your 
overall health,” on a scale of 1 to 5 with 5 representing excellent health. Trust in physician was measured in a 
pre-visit survey with the statement, “I trust this doctor’s judgment about my medical care.”  Patients rated their 
agreement on a scale of 1 to 7 with 7 representing “strongly agree”. 
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Patient initial response to recommendation and occurrence of patient-defined SDM 
components 
Across the 410 visits, the most common initial response to a physician recommendation 
of colorectal cancer screening was some type of hesitation or pushback from the patient (43%; 
Table 4.2).  Another 22% of patients were observed to verbally agree with the recommendation, 
while about 10% initially refused.  For the remaining quarter of patients, there was no verbal 
indication of their response to the physician recommendation.  The most commonly observed 
patient-defined SDM component was patient self-advocacy, which occurred in over three-
quarters of the visits.  More than half of the visits contained an exchange of information around 
colorectal cancer screening (61%) and physician active listening (60%).  A personalized 
physician recommendation for colorectal cancer screening was observed in less than a quarter of 
visits (23%).  In total, only 35 visits (9%) contained all four components of patient-defined 
SDM.   
There were significant differences in the occurrence of two of the patient-defined SDM 
components by initial response category (Table 4.2).  Specifically, patients who verbalized 
hesitancy about screening were more likely to receive information about process or potential side 
effects of colorectal cancer screening than patients overall (75% vs. 61%; OR: 2.14 95% CI: 
1.58, 2.88), while those who agreed or who did not disclose their response were less likely to 
have received screening information (For agree:  47% vs. 61%; OR = 0.64; 95% CI: 0.44, 0.92; 
For no verbal response: 47% vs. 61% OR: 0.63; 95% CI: 0.47, 0.86).  Second, physicians were 
more likely to have practiced active listening with patients who initially refused the 
recommendation than with patients overall (70% vs. 60%; OR: 1.53; 95% CI: 1.00, 2.34), and 
were less likely to actively listen to those who did not verbally respond (51% vs. 60%; OR: 0.67; 
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95% CI: 0.49. 0.91). Neither receipt of a personalized physician recommendation nor patient 
self-advocacy varied significantly by the patient’s initial response to the recommendation for 
screening, but those who verbalized initial hesitancy about the recommendation were most likely 
to receive all four components of patient-defined SDM (14% vs. 9%; OR: 2.32; 95% CI: 1.30, 
4.11). 
 
Table 4.2 Occurrence of SDM components overall and by patient initial verbal response to 
recommendation for colorectal cancer screening 
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Relationship between patient-defined SDM components and colorectal cancer screening  
 Overall, 55% of the sample went on to be screened for colorectal cancer in the year 
following their recorded visit.  In bivariate analyses, none of the four components of patient-
defined SDM individually were significantly associated with colorectal cancer screening 
adherence, nor was receipt of all four components (data not shown).  However, there were 
significant differences in screening rates by the patient’s initial verbal response to the physician 
recommendation for colorectal cancer screening.  Specifically patients who initially refused were 
less likely than the overall sample to be screened (40% vs. 55%; OR: 0.59; 95% CI: 0.35, 0.98), 
while those who did not provide a verbal indication of their response were more likely to be 
screened (70% vs. 55%; OR: 2.00; 95% CI: 1.37, 2.93).  In both the unadjusted and adjusted 
main effects models, only patients who did not provide an initial verbal response to the screening 
recommendation were significantly more likely to be screened than other patients  (Table 4.3, 
Models 1 and 2, see page 77).   
Interaction between patient-defined SDM components and patient’s initial response to 
recommendation 
Table 4.4 descriptively displays the percentage of patients who were adherent to their 
physician’s colorectal cancer screening recommendation by the patient’s initial response 
category and receipt of the SDM components.  When the interactions between each of the 
patient-defined SDM components and the patient’s initial response to the recommendation are 
added to the model (Table 4.3, Model 3), patients who did not provide an initial response to the 
screening recommendation remain more likely to be screened (OR: 2.13; 95% CI: 1.30, 3.48), 
and those who initially refuse the recommendation remain less likely to be screened (OR: 0.32; 
95% CI: 0.12, 0.86).  Additionally, in the model that adjusted for the effects of pre-existing 
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patient, physician, and communication climate characteristics  (Table 4.3, Model 4), patients 
who receive information from their physician about the colorectal cancer screening process or its  
potential side effects are more likely to be screened than those who do not (OR: 1.78; 95% CI: 
1.02, 3.10).  None of the interaction terms reached significance in either the unadjusted or 
adjusted model. 
 
Table 4.4 Percent adherent to CRCS recommendation by initial response category and 
receipt of SDM components 
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Discussion 
While results here do not provide strong evidence for the effect of patient-defined SDM 
on adherence to physician-recommended colorectal cancer screening, I did find that, controlling 
for other communication factors, patients who received information about the process or 
potential side effects of colorectal screening were more likely to be adherent to their physician’s 
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recommendation for screening.  Additionally, I found significant differences in both screening 
rates and receipt of the components of patient-defined SDM by the patient’s initial verbal 
response to their physician’s recommendation for CRC screening.  This implies that physicians 
tailor their conversation to the patient’s initial verbalized level of agreement with the their 
recommendation.  Furthermore, while, expectedly, patients who initially refused the 
recommendation were those least likely to be screened, it was not patients who expressed initial 
agreement with the recommendation, but those who offered no response, who were most likely 
to be screened.   
In this sample, patient-defined shared decision making in the context of colorectal cancer 
screening was not provided consistently across patients. While all visits contained a physician 
recommendation for screening, almost 40% of did not include information about the screening 
process or its possible side effects.  Furthermore, a personalized recommendation, in which the 
physician explained why colorectal cancer screening is important in general and for that patient 
in particular, was only observed in fewer than one-quarter of visits.  In total, only 9% of visits 
included all four components of patient-defined SDM, and this was most likely to occur in 
patients who expressed hesitancy, but even then only 14% experienced all four elements of 
patient-defined SDM.  These results support other studies that have found that, in the context of 
colorectal cancer screening, shared and informed decision making rarely occurs in practice. 126,127 
Thus, evaluating the impact of SDM on colorectal cancer screening in practice remains 
problematic. 
My results have implications for primary care practice.  First, primary care physicians 
should be cautious about assuming that they can tell whether a patient intends to be screened or 
not based on the patient’s initial, verbal reaction to their recommendation for screening.  Results 
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here indicate that the majority of patients who initially offer a statement of agreement to a 
physician recommendation to be screened for colorectal cancer do not actually do so within the 
following year.  On the other hand, less than a third who offer no responses at all to their 
physician’s screening recommendation remain unscreened one year later.  Thus, it would seem 
important to engage patients in further discussion regardless of their initial response, providing 
patients additional opportunities to express their intents and concerns.   
 Second, over half of the patients in this sample verbalized some kind of hesitation or 
pushback against colorectal cancer screening.  As previously reported, in this sample 118 and 
elsewhere across the nation, 127 physicians are increasingly recommending colonoscopy for CRC 
screening without offering alternatives. When physicians hear hesitancy about colonoscopy, they 
should assess whether this hesitancy is for screening in general versus specifically for 
colonoscopy.  Patients who are resistant to colonoscopies may be more open to the idea of a fecal 
occult blood test. 128 A recent trial found that patients offered a choice among modalities were 
more likely to be screened. 129 At the very least, physicians should provide information around 
the process of colorectal cancer screening to all patients along with their recommendation for 
screening. In this sample, those who received such information were significantly more likely to 
be screened regardless of their initial verbal response to their physician’s recommendation for 
screening. 
This study also has implications for future research around SDM and colorectal cancer 
screening. In absence of an available measure of the patient’s screening intent at the beginning of 
the visit, I relied on the patient’s initial stated level of agreement with the physician 
recommendation as a proxy for their initial level of agreement with the recommendation to be 
screened.  The benefit of relying on patients’ verbal responses is that this is the same information 
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that physicians have at the time of the visit. Thus, there is value in evaluating patients’ verbalized 
level of agreement, despite the fact that this may not accurately represent the patient’s actual 
feelings about the recommendation.  However, because this study used audio-recordings instead 
of video-recordings or direct observation, I was not able to account for body language that might 
have provided additional information about the patients’ initial reactions to the recommendation 
for colorectal cancer screening. In order to more fully test the model of patient-defined SDM, 
future studies should consider the use of video recordings and measure the patient’s actual intent 
to be screened, both before and after the visit, and compare this with verbal responses.  Second, 
while there has been a trend towards evaluating the effects of SDM on more distal patient 
outcomes like adherence 66,69 or blood pressure, 70,84 SDM—whether patient defined or otherwise 
measured—is most likely to affect proximal outcomes like satisfaction and decisional regret. 101 
While it is valuable to evaluate the effect of patient-physician communication on outcomes such 
as adherence or more distal health outcomes, SDM might be better advocated on the grounds of 
helping patients make informed and value-concordant decisions. 45,46 
This study has several limitations.  First, the availability of only one recorded visit per 
patient-physician dyad precludes the ability to test for the effects of SDM over time. Many of the 
patients in this sample have a long-standing relationship with their physician, and there may have 
been more active discussion around colorectal cancer screening in previous visits.  I did however 
control for trust as expressed by the patient prior to the visit.  Also, despite the fairly large 
sample size, the power to detect differences is limited by the clustering by physician and the 
large number of predictors after the interaction terms were added.  Nevertheless, the stability of 
my findings when the patient and physician covariates were added suggests robust results.   
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In conclusion, further research is needed to fully establish a link between patient-defined 
SDM and colorectal cancer screening.  However, the results presented here indicate that, 
regardless of a patient’s initial reaction to a physician recommendation for screening, those who 
are provided with information about the screening process are more likely to be screened in the 
following year.  Thus, providing information to all patients at the time of a colorectal cancer 
screening recommendation is critical, both to allow for more informed decision-making and for 
improving colorectal cancer screening rates. 
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Table 4.3 Factors associated with colorectal cancer screening 
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Chapter 5:  Conclusions 
 
 
 
 The results from the three studies presented in this dissertation build on one another.  
First, the systematic review of the measurement of SDM and its effects on patient outcomes 
found that SDM is typically measured in one of three ways:  via patient-self report; physician 
self-report; or objective rating of recorded or observed interactions between patients and 
clinicians.  Drawing from past theoretical models, 47,48 my review offers a novel categorization 
framework for examining the impact of SDM across two domains: the way in which SDM was 
measured and the category of patient outcomes (cognitive, behavioral, or health-related).  While 
there has been a recent trend towards linking (or trying to link) SDM with patient outcomes, 47,97-
99 this was the first study to systematically summarize the associations between different 
measures of SDM and types of patient outcomes.  
 The systematic review had several important results that guided the direction and 
methodology of the subsequent studies.  First, only patient reports of SDM were consistently 
associated with patient outcomes.  Of the 97 unique patient outcomes evaluated in association 
with a measure of SDM, 52% of outcomes measured in conjunction with patient reports of SDM 
were found to have a significant and positive association, versus only 21% with observer rated, 
and 0% with clinician-rated SDM.  This finding suggests two important points: the link between 
SDM and outcomes has yet to be established, and when there are significant findings only patient 
reports of SDM that are consistently linked with patient outcomes.  Across studies using patient-
reports of SDM, the most commonly used measure was a modification of the Control Preference 
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Scale. 12 This single item instrument asks patients to rate their involvement in a specific decision 
across five categories.   What the instrument does not do, however, is aid in an understanding of 
what SDM means to patients and what needs to happen in a patient-clinician interaction for a 
patient to label a decision as shared.  In order to foster the benefits of patient-perceived SDM in 
practice, we need a better understanding of what leads patients to report a decision as shared.   
 Building on these findings, the aims of my second study were to understand how patients 
define SDM in general and what leads patients to label a specific decision as shared in practice.  
Through in-depth qualitative interviews with 23 patients who had recently attended a primary 
care visit, these aims were explored.  Findings from this study indicate that patients conceptually 
define SDM similar to academic definitions of SDM (e.g. Charles et al. 5), with some important 
caveats.  Specifically, patients described an interactive process that included four communication 
components before a decision was made: an exchange of information; active listening; patient 
self-advocacy; and a personalized physician recommendation.  Additionally, patients reported 
that this process occurs in the context of a trusting relationship that is built over time.  In 
contrast, when asked about specific decisions made at a recent primary care visit, for that 
decision to be labeled as shared using the modified Control Preference Scale, 12 patients 
described a variety of exchanges ranging from interactive to very simple.  The only commonality 
among decisions labeled as shared by patients was that the patient and physician came to 
agreement.  In cases where patients reported agreeing with their physician’s initial 
recommendation, even very simple interactions were labeled as shared.  Results from this study, 
therefore, indicated that the discussion content that is needed for a patient to label a specific 
medical decision as having been shared may vary by the patient’s initial level of agreement to a 
physician’s recommendation.   
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For my last study I used the conceptual model of SDM that I developed in study two and 
coded for the four components of patient-defined SDM in an existing database of audio-recorded 
primary care visits.  In this study, I explicitly tested whether the occurrence of the components of 
patient-defined SDM were associated with adherence to physician-recommended colorectal 
cancer screening, and whether the relationship between patient-defined SDM and adherence to 
colorectal cancer screening was moderated by the patient’s initial verbal response to the 
physician recommendation.  This study found that, first, patient-defined SDM was not happening 
regularly in the context of colorectal cancer screening discussions.  Second, patients who initially 
verbally agreed to a physician recommendation for colorectal cancer screening were not more 
likely to be screened, and instead it was those who provided no verbal response who were 
screened at the highest rates.  Finally, physician provision of information about the colorectal 
cancer screening process was significantly associated with screening, regardless of the patient’s 
initial response to the screening recommendation.  
Taken together, the results from these three studies have implications for practice and 
research around shared decision making. Patient perceptions of SDM, rather than physician 
perceptions or observer ratings based on academic definitions of SDM, are most likely to impact 
patient outcomes.  The three studies presented here are relatively novel in their explicit focus on 
the patient perspective of SDM, giving a voice to those who SDM is meant to benefit.  In 
contrast with traditional definitions of SDM, patients emphasize the importance of a trusting 
relationship and other relational factors.  In order to encourage patient-perceived SDM and its 
benefits in practice, physicians should work to facilitate trust by actively listening to patients and 
providing recommendations that are personalized to the patient based on their unique 
circumstances and preferences.  Also, while a patient’s initial level of agreement with a 
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physician recommendation may affect perceptions of SDM, physicians cannot take verbalized 
agreement at face value.  Patients who quickly agree with recommendations may not necessarily 
adhere.  Furthermore, all patients, including those who seem to already agree with a 
recommendation, could benefit from the provision of additional information, particularly in the 
context of colorectal cancer screening. 
My findings also highlight the complexity of studying and measuring shared decision 
making.  First, definitions of SDM overlap with several other communication processes often 
discussed in the literature including informed decision making, patient-centered communication, 
action planning, and collaborative goal setting.  While the overlap of terms likely cannot be 
avoided, researchers should explicitly describe the communication process that they are 
studying, and include an operational definition of the term, so that results can be compared 
across studies.  Second, as the findings from this dissertation demonstrate, both the meaning and 
the effect of SDM differ depending on the way it is measured.  My systematic review revealed 
that the association between SDM and patient outcomes differs by measurement perspective, 
with patient self-reports of SDM being more likely to be associated with outcomes than other 
types of measures.  Additionally, in the qualitative study, patient’s perceptions of SDM differed 
by the way they were asked about SDM.  Third, the study of SDM is complex because of the 
transactional nature of communication between patients and clinicians. 117  The communication 
patterns of clinicians effect the communication patterns of patients and vice versa.  Therefore, it 
is difficult to make any blanket statements about when SDM occurs or when it will have an 
effect on outcomes.  Both the occurrence and impact of SDM are impacted by a myriad of 
factors including, but not limited to, the context and acuity of the decision being made, the prior 
relationship between the patient and clinician, that patient’s level of initial agreement with a 
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physician recommendation, the match between patient and clinician communication styles and 
decision-making preferences, as well as other pre-existing characteristics that patients and 
clinicians bring to the encounter.  Thus, there is no simple formula for promoting perceptions of 
SDM or its associated outcomes.   
It is important to note that, due in part to these complexities in studying SDM, the link 
between SDM and patient outcomes has yet to be fully established.  Relatively few studies have 
explicitly measured SDM in association with any patient outcome and even more rarely with 
more distal health outcomes.  SDM is most likely to be positively associated with patient 
outcomes when it was measured via patient self-report and when the outcomes measured were 
proximal outcomes like satisfaction or decisional conflict.  While this finding may not be 
satisfactory to those who wish to link SDM to patient health outcomes, the lack of association is 
not surprising.  In their model of pathways linking communication to outcomes, Street and 
colleagues posit that the effects of SDM on health outcomes are likely to be indirect, with SDM 
first impacting more proximal outcomes, 47 
 Additionally, there is increasing recognition that SDM is a process that often occurs over 
the course of multiple visits. 107 Findings from my qualitative interviews supported this, with 
patient’s reporting that an essential factor in SDM is a trusting relationship with the physician 
that is often built over time.  Until now, SDM is almost always measured cross-sectionally in the 
context of one interaction or discussion.  This may, in part, explain the lack of association 
between SDM and patient comes, including colorectal cancer screening adherence.  That is, one 
discussion between a clinician and patient may not lead to improved health outcomes, but a long-
standing relationship between a clinician and patient marked by patient-centered care and SDM 
may impact outcomes over time.  Future studies should measure multiple outcomes over time so 
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that the pathway between communication and health outcomes, such as that proposed by Street 
and colleagues, 47 can be tested.  For example, SDM may improve patient satisfaction, which 
over time may lead to trust in the physician, followed by adherence to physician 
recommendations and ultimately improved health. 130 Without longitudinal studies that 
specifically test for indirect effects in addition to direct effects, however, the link between SDM 
and health outcomes is likely to remain elusive. 
In the meantime SDM may be better advocated on ethical grounds.  Patient centered care, 
including SDM, is important outside of its potential effect on patient health outcomes.  First, 
most patients want to be actively involved in the decision-making about their medical care, 42 
and SDM helps accomplish this goal. Second, SDM is historically rooted in the discipline of 
bioethics. One of the earliest mentions of SDM was the 1982 Report of the President’s 
Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral.  
This report called for a dialogue between patients and practitioners in which both voice opinions 
and concerns, and come to a mutually agreed upon decision.  Accordingly, the report states that 
“ethically valid” consent should be part of a shared decision making process characterized by 
mutual respect and participation. 39 More recently, the U.S. Preventive Task Force highlighted 
the multiple perspectives on which SDM can be recommended.  These included an ethical 
mandate to protect patient autonomy and self-determination, an interpersonal benefit of 
promoting trust in the patient-clinician relationship, and an educational gain of increasing patient 
knowledge about treatment options, benefits, and harms through a SDM process. 3 Thus, despite 
only limited evidence that shared decision making improves patient outcomes, there are still 
important reasons to advocate for a SDM process when making healthcare decisions.   
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Appendix A 
 
 
Patient Interview Guide 
 
Introduction: 
Thank you again for agreeing to participate in this interview.  We are interested in 
learning about how patients and doctors make decisions. There are no right or 
wrong ways to make decisions with doctors.  I am interested in hearing about 
your experience and opinions. 
 
I am going to ask some questions about how you and your doctor discussed certain 
health decisions.  Please consider what happened at your most recent visit with your 
doctor, Dr X, as we talk. 
  
 
1. Let’s start by talking about some of the topics that you and Dr.__ discussed 
during your most recent visit.  Please tell me what topics you discussed. 
 
INTERVIEWER: Prompt (if patient cannot remember any topics): 
Sometimes doctors and patients talk about lifestyle choices, preventive 
services like cancer screening, medications, etc.  
 
 
2. Were any decisions made about any of these topics?  Which ones? 
 
Prompt with the topics raised in Q1 to see if any decisions were made 
about these topics.  
INTERVIEWER:  List all relevant topics and then review each with 
the patient 
INTEVIEWER: If no decisions were made about topics listed, ask 
about a past health care decision made with a physician that 
included some of these topics. 
 
 
3. I’d like to hear more about the decision about <topic>?  How was that decision 
made? 
 
 
4. Now I am going to read you 5 choices for how the decision was made.  There are 
no right or wrong ways to make the decision, so none of these choices are better 
or worse.   
 
 
!
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When it came to making the decision about <topic>, which of these would you 
say would best describe how the decision was made?  
 
a) I made the final decision.  
b) I made the final decision after seriously considering my doctor’s opinion. 
c) My doctor and I shared the responsibility for deciding.  
d) My doctor made the final decision after seriously considered my opinion. 
e) My doctor made the final decision. 
 
 
5. So, you just told me that the decision about <topic> was one made by X/X.   Can 
you tell me what makes you feel that the decision about <topic> was <type of 
decision chosen in Question 4>?  
 
• What specific things happened during the visit that made you feel that 
<type of decision chosen in Q4>? 
 
• What specific things did your doctor do or say that made you feel this 
way? 
 
• What specific things did you do or say that made you feel this way? 
 
• If someone were to have audio-recorded or video-recorded your visit with 
Dr. X, how would they have known from the audio or video that the 
decision was <type of decision choices in Q4>? 
 
• Is this typical of how you usually make decisions with Dr X? 
 
 
6. IF THE RESPONSE TO Q4 WAS NOT MARKED AS SHARED (Q4 CHOICE C):   
You have shared that you did not feel that the decision you made about <topic> 
was shared with your physician.  What would have had to happen for you to say 
that you and your doctor shared responsibility for deciding about <topic>? 
 
a. What specific things would have had to happen during the visit to make 
you think that this decision was shared? OR 
 
i. What would have been different from what actually happened for 
you to feel that the decision was shared? 
 
b. What specific things would your doctor have had to do or say?  
 
c. What specific things would you have had to do or say? 
 
 
   ***REPEAT QUESTIONS 3-6 ABOUT ALL DECISIONS RAISED IN Q2*** 
!
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7. What does the phrase “My doctor and I shared responsibility in deciding” mean to 
you?  What kinds of things do you think of when you hear this phrase? 
 
 
As you probably know, things have changed in health care and now, many 
patients are taking more active roles in making decisions about their health care. 
This is often called ‘shared decision making’. What I am interested in learning is 
what this means to patients.  
 
 
8. What do you think of when you hear shared the words, ‘shared decision-making’ 
between doctors and patients? What does it mean to you? 
 
 
9. What things must you, as a patient, do during the conversation for you to 
consider a health care decision to be shared between you and the doctor?  
 
 
10. What things must the doctor do during the conversation for you to consider a 
health care decision to be shared between you and the doctor?  
 
 
11. In your opinion, what is the difference between the options “I made the final 
decision after seriously considering my doctor’s opinion” and “My doctor and I 
shared the responsibility for deciding”? 
 
Can you give me examples of these from your experiences? 
 
 
12. In your opinion, what is the difference between the options “My doctor made the 
final decision after seriously considering my opinion” and “My doctor and I shared 
the responsibility for deciding”? 
 
Can you give me examples of these from your experiences? 
 
 
13. One of the most common definitions of shared decision-making is that four things 
have to happen: 
 
1) Both the doctor and the patient have to be actively involved in the 
decision-making process 
2) Both the doctor and the patient share information with each other 
3) Both the doctor and the patient express treatment preferences 
4) Both the doctor and patient agree on a decision   
!
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 What do you think about this definition of shared decision-making? 
 
 Do you think both the doctor and patient have to be actively involved?   
  Tell me more about that… 
 
Do you think both the doctor and patient need to share information with 
each other for the decision to be shared?   
  Tell me more about that… 
 
Do you think that both the doctor and the patient need to take steps to 
build a consensus around the decision for it to be shared? 
 Tell me more about that… 
 
Do you think that both the doctor and patient need to agree on a decision 
for it to be shared? 
 Tell me more about that… 
 
 Would you make any additions or changes to the definition? 
 
 If you were making up a definition of shared decision-making, what would it be? 
 
 
14. Do you think that every single decision made about your health care should be a 
shared one between a doctor and patient? 
 
 
15. Are there differences in how major and minor health decisions should be made? 
(examples: lab work, cancer screening (like colonoscopy), treatment 
decisions (surgery, cancer treatment, etc.)) 
 
 
16. Is there anything else that I didn’t ask that is important for us to know about 
decision-making between doctors and patients?   
 
Thank you so much for your time.  We hope that the information you have given 
us will help improve decision-making for future patients.   
 
!
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Appendix B 
 
 
Final Code List for Patient Interviews 
 
!
Code Name Description 
  
Q1 - Topics discussed Code for marking topics discussed in transcript 
Q2 - Decisions made Code for marking decisions made in transcript 
Q3 - Description of Decision Code for marking description of decisions made in 
transcript 
  
Context Codes for marking the context of specific 
decision being discussed in questions 3, 4, 
and 5 
 Context - Blood pressure tx  
 Context - Blood work  
 Context - Bone density scan  
 Context - Cholesterol tx  
 Context - Colonoscopy  
 Context - Insomnia meds  
 Context - Mammography  
 Context - Medication  
 Context - Referral for procedure  
 Context - Referral to specialist  
 Context - Shingles vaccine  
 Context - Sleep study  
  
Q4 Patient response to the modified control 
preference scale in the context of a specific 
decision listed in Q3 
Q4 - Degner CPS - Pt alone I made the final decision.  
Q4 - Degner CPS - Pt led I made the final decision after seriously considering 
my doctor’s opinion. 
!
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Q4 - Degner CPS - Shared My doctor and I shared the responsibility for 
deciding.  
Q4 - Degner CPS - Dr led My doctor made the final decision after seriously 
considered my opinion. 
Q4 - Degner CPS - Dr alone My doctor made the final decision. 
  
  
When describing a specific decision that they 
labeled as shared in Q4 … 
Shared type  - Simple agreement    patient describes a process in which the doctor 
makes a recommendation, and the patient 
describes simply agreeing 
Shared type - Pt request    patient describes a process in which the patient 
brings in a specific request and the physician 
agrees 
Shared type - Pt pushback    patient describes a process in which the doctor 
makes a recommendation, the patient is 
hesitant or disagrees and pushes back, they 
discuss and ultimately come to agreement 
  
Q5 When asked about a specific decision labeled as 
shared... 
Q5 - Info     patient brings up the concept of sharing or 
exchanging information 
Q5 - Info - Dr shares info    patient says the doctor shared information 
Q5 - Info - Dr shares info- 
recommend 
   patient says that the doctor made a 
recommendation 
Q5 - Info - Pt shares info - 
expresses concerns 
   patient says that he/she expressed concerns 
Q5 - Info - Pt shares info - shares 
symptoms 
   patient says that he/she shared symptoms or other 
problems 
Q5 - Listen    patient explicitly brings up the concept of listening 
Q5 - Listen - Dr listens    patient explicitly says the their doctor listened 
Q5 - Listen - IMPLIED    patient does not use the word "listen" but the 
process they describe implies listening 
Q5 - Listen - Pt listens    patient explicitly says that they listened to their 
doctor 
!
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Q5 - Decide    patient explicitly says that a decision was made 
Q5 - Decide - Agree    patient says that the patient and physician agreed 
on the decision 
Q5 - Decide - Best for individual 
patient 
   patient says that the decision was made in the 
patient's best interest 
Q5 - Decide - Decide together    patient says that the doctor and patient decided 
together 
Q5 - Decide - Pt decides    patient says that they made the decision 
Q5 - Rapport    patient brings up the concept of relationship or 
rapport 
  
Q6 & Q7 When asked about SDM in general… 
Q7 - Info     patient brings up the concept of sharing or 
exchanging information 
Q7 - Info - Dr shares info    patient says that doctors should share information 
Q7 - Info - Dr shares info - gives 
opinion 
   patient says that doctors should give their opinion 
Q7 - Info - Dr shares info - gives 
options 
   patient says that doctors should share options 
Q7 - Info - Dr shares info - 
recommend 
   patient says that doctors should make a 
recommendation 
Q7 - Info - Dr shares info - 
recommend - no demand 
   patient says that physicians should not make 
demands or ultimatums when making 
recommendations 
Q7 - Info - Pt shares info    patient says that patients should share information 
Q7 - Info - Pt shares info -  gives 
opinion 
   patient says that patients should share their 
opinion 
Q7 - Info - Pt shares info -  
shared symptoms/problem 
   patient says that patients should share any 
relevant symptoms or problems 
Q7 - Info - Pt shares info - asks 
questions 
   patient says that patients should ask questions 
Q7 - Info - Pt shares info - 
expresses concerns 
   patient says that patients should express their 
feelings or concerns 
Q7 - Listen    patient explicitly brings up the concept of listening 
Q7 - Listen - Dr listens    patient explicitly says that doctors should listen to 
patients 
Q7 - Listen - IMPLIED    patient does not use the word "listen", but listening 
!
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is implied in the process that they describe 
Q7 - Listen - Pt listens    patient explicitly says that patients should listen to 
doctors 
Q7 - Decide    patient brings up the concept of a making a 
decision 
Q7 - Decide - Agree    patient says that doctors and patients should come 
to an agreement 
Q7 - Decide - Best for patient    patient says that doctors and patients should make 
a decision in the best interest of the patient 
Q7 - Decide - Decide together    patient says that doctors and patients should 
decide together 
Q7 - Decide - Pt decides    patient says that the patient ultimately decides 
Q7 - Rapport    patient brings up the concept of relationship or 
rapport 
Q7 - Rapport - Dr knows pt    patient says it is important for the doctor to know 
the patient before making recommendations 
Q7 - Rapport - Honesty    patient brings up the concept of honesty 
Q7 - Rapport - Respect    patient brings up the concept of respect 
Q7 - Rapport - Trust    patient brings up the concept of trust 
Q7 - OTHER - Accessibility     patient says that accessibility of the doctor outside 
of the visit is important 
Q7 - OTHER - Choice    patient says that they should be offered choice 
Q7 - OTHER - Pt allowed time     patient says that patients should be allowed time to 
make decisions 
Q7 - OTHER - Pt follow-through    patient says that the patient needs to follow 
through with actions required by the decision 
Q7 - OTHER - Pt take 
responsibility 
   patient says that patients need to take 
responsibility for their decisions and/or health 
Q7 - OTHER - Pt understands    patient says it is important that patients understand 
the decision at hand 
  
Q9 When asked what things patients must do during 
the conversation for it to be considered a 
shared decision… 
Q9 - Ask for second opinion    patient says they should ask for a second opinion if 
needed 
Q9 - Ask questions    patient says they should ask questions  
!
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Q9 - Be honest    patient explicitly listed being honest 
Q9 - Be open-minded    patient says they should be -open-minded to the 
physician's opinion and/or recommendation 
Q9 - Be prepared    patient says they should come prepared for the 
visit 
Q9 - Direct doctors to topic of 
interest 
   patient says they should direct doctors to the 
topics they want to discuss 
Q9 - Express opinions    patient says they should express their opinions if 
they have one 
Q9 - Make decision    patient says they should ultimately make the 
decision 
Q9 - Share info    patient says they should provide all relevant 
information 
Q9 - Speak up     patient says they should speak up if uncomfortable 
with decision or recommendation 
  
Q10 When asked what things doctors must do during 
the conversation for it to be considered a 
shared decision… 
Q10 - Answer pt questions    patient says that doctors should answer patient 
questions or address concerns 
Q10 - Be honest    patient explicitly says that the doctors should be 
honest with patients 
Q10 - Be open-minded    patient says that doctors should be open-minded 
to patient requests and opinions, being  willing 
to stray from usual approach 
Q10 - Check for agreement    patient says that doctors should check for patient 
agreement and understanding 
Q10 - Give information    patient says that doctors should give information to 
patients 
 
Q10 - Give reasons for 
recommendation 
   patient says that doctors should check for patient 
agreement and understanding 
Q10 - Know patient    patient says that doctors should get to know 
patients before making recommendations 
Q10 - Listen to patient    patient says that doctors should listen to patients  
Q10 - Provide options    patient says that doctors should provide patients 
with options 
!
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Q10 - Respect    patient says that doctors should respect the 
patients 
Q10 - Share opinion    patient says that doctors should share their opinion 
with patients 
Q10 - Solicit involvement    patient says that doctors should solicit patient 
questions, concerns, symptoms 
Q10 - Take time    patient says that doctors should take the time to 
have a conversation with patient and not rush 
Q10 - Understand patient 
symptoms/concerns 
   patient says that doctors should understand patient 
symptoms and concerns 
 
!
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